perindopril has been researched along with Blood Pressure, High in 818 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (4.77) | 18.7374 |
| 1990's | 185 (22.62) | 18.2507 |
| 2000's | 335 (40.95) | 29.6817 |
| 2010's | 214 (26.16) | 24.3611 |
| 2020's | 45 (5.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barbashina, TA; Gavriljuk, EV; Mal, GS; Pribylov, CA; Pribylov, VS; Pribylova, NN; Yakovleva, MV | 1 |
| Abeel, M; Constance, C; Gupta, A | 1 |
| Aje, A; Albertino, D; Barasa, F; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, ESW; Mondo, C; Ogah, OS; Ogola, E; Ojji, DB; Rayner, B; Sani, M; Shahiemah, P; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W; Stewart, S | 1 |
| Belenkov, YN; Danilogorskaya, YA; Ilgisonis, IS; Kozhevnikova, MV; Lishuta, AS; Privalova, EA; Zektser, VY; Zheleznykh, EA | 1 |
| Hassan, D; Koch, BCP; Peeters, LEJ; Versmissen, J | 1 |
| Goreva, LA; Karapetyan, LV; Kobalava, ZD; Kolesnik, EL; Shavarova, EK | 1 |
| Syed, YY | 1 |
| Abdelsattar, AT; Cherfaoui, O; Elmoursi, A; Farhat, AM; Habboush, S; Masoud, AT; Sofy, AA | 1 |
| Ackbarkhan, A; Mbanya, A; Mbanya, JC; Mittoo, MY; Ramamonjisoa, HA; Ramilitiana, B; Ranivoharisoa, EM; Ratsimbazafy, SJN | 1 |
| Borghi, C; Cicero, AFG; D'Addato, S; Fogacci, F; Giovannini, M; Rizzoli, E | 1 |
| Gavrilova, A; Latkovskis, G; Urtāne, I; Zolovs, M | 1 |
| Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Hickman, N; Ingabire, PM; Jones, E; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Pandie, S; Partington, G; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
| Elmoursi, A; Kamel, IS; Kassem, A; Khalil, F; Mancy, IME; Mohamed, SED; Mostafa, S; Ramadan, IG; Shabana, H; Zedan, HA | 1 |
| Batacan, R; Connolly, K; Fenning, A; Jackson, D; Vella, R | 1 |
| Brzozowska-Villatte, R; Chalmers, J; De Champvallins, M; Mancia, G; Mourad, JJ | 1 |
| Boloban, A; Džananović Jaganjac, J; Glamočlija, U; Mehić, M; Popović, Ž; Šukalo, A; Tanović Avdić, A; Tirić Čampara, M | 1 |
| Cs, S; Jawed, S | 1 |
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, A; Perrone, V; Snyman, JR | 1 |
| Chen, S; Dong, P; Liu, H; Zhao, D | 1 |
| Burtsev, Y; Kobalava, Z; Kvasnikov, B | 1 |
| Souček, M | 2 |
| Kang, Y; Lee, CJ; Lee, JH; Lee, SH; Park, JM | 1 |
| Borghi, C; Bortolotto, LA; Degli Esposti, L; Jayagopal, PB; Konradi, AO; Perrone, V; Snyman, JR | 1 |
| Alaba, OA; Gumedze, F; Jones, ESW; Ntusi, NAB; Snyman, JR; Tsabedze, N; Vira, A | 1 |
| Degli Esposti, L; Gambera, M; Nati, G; Perone, F; Perrone, V; Tagliabue, PF; Veronesi, C; Volpe, M | 1 |
| Jabre, G; Joseph, S; Kalra, S; Rajarshi, M; Shah, SN; Sosale, A | 1 |
| Chalmers, J; Hamet, P; Harrap, S; Lee, AK; Marre, M; Mcevoy, JW; Ohkuma, T; Selvin, E; Sharrett, AR; Wang, D; Warren, B; Williams, B; Woodward, M | 1 |
| Glezer, MG | 1 |
| Onakpoya, I | 1 |
| Lenti, S; Mazza, A; Rigatelli, G; Rossetti, C; Rubello, D; Schiavon, L; Torin, G; Townsend, DM | 1 |
| Andor, M; Bâibâță, DE; Bordejevic, DA; Buda, V; Coricovac, D; Crainiceanu, Z; Cristescu, C; Dalleur, O; Danciu, C; Ledeti, I; Muntean, DM; Petrescu, L; Tomescu, MC; Tudor, A | 1 |
| Cooper, ME; Knudsen, ST | 1 |
| Tůmová, E; Vrablík, M | 1 |
| Argyris, AA; Protogerou, AD; Samara, S | 1 |
| Belenkov, YN; Danilogorskaya, YA; Khabarova, NV; Kozhevnikova, MV; Lishuta, AS; Privalova, EA; Shakaryants, GA; Shchendrigina, AA; Zektser, VY; Zheleznykh, EA | 1 |
| Fendrikova, AV; Gutova, SR; Skibitskiy, AV; Skibitskiy, VV | 1 |
| Begrambekova, YL; Levin, AM; Mareev, VY; Minina, YV | 1 |
| Zlatohlávek, L | 1 |
| Chaudhary, G; Joseph, S; Konda Reddy, KM; Murthy, LS; Nikam, P; Rajarshi, M; Sawhney, JP; Shah, S; Thacker, H | 1 |
| Kochetkov, AI; Ostroumova, OD; Ostroumova, TM; Parfenov, VA; Perepelov, VA; Perepelova, EM | 1 |
| Brzozowska-Villatte, R; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y | 1 |
| Moskaleva, PV; Nasyrova, RF; Petrova, MM; Shnayder, NA | 1 |
| Amaral, SL; Duchatsch, F; Macedo, AG; Miotto, DS; Ruiz, TFR; Vicentini, CA | 1 |
| Ancion, A; Lancellotti, P; Scheen, AJ | 1 |
| Brzozowska-Villatte, R; De Champvallins, M; Dézsi, CA; Farsang, C; Glezer, M; Karpov, Y | 1 |
| Chalmers, J; Harrap, S; Harris, K; Mancia, G; Marre, M; Poulter, N; Rodgers, A; Tzourio, C; Wang, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Boytsov, SA; Burtsev, YP; Karpov, YA; Khomitskaya, YV | 1 |
| Kuker, W; Li, L; Rothwell, PM; Warlow, CP; Zuurbier, SM | 1 |
| Arablincky, NA; Kirichenko, AA; Kochetkov, AI; Ostroumova, OD; Romanovsky, RR; Shatalova, NA | 1 |
| Amar, L; Barigou, M; Calvet, D; Dominiczak, AF; Guzik, T; Jennings, G; Laurent, S; Rossi, GP; Touyz, RM; Turc, G | 1 |
| Kotsis, VT; Liakos, CI; Papadopoulos, DP | 1 |
| Ábrahám, G; Dézsi, CA | 1 |
| Glezer On Behalf Of The Forsage Program Participants, MG | 1 |
| Ezhova, N; Kobalava, Z; Troitskaya, E | 1 |
| Chumachek, EV; Judina, JS; Khripaeva, VJ; Konradi, AO; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV; Zvartau, NE | 1 |
| Chung, E; Ortiz, M; Simons, LA | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Chalmers, J; Ferrari, R; Fox, K; MacMahon, S; Remme, W; Simoons, ML | 1 |
| Ferenci, T; Finta, E; Gasparics, R; Medvegy, M; Simonyi, G | 1 |
| Radermecker, RP | 1 |
| Bistrika, EA; Elliott, WJ | 1 |
| Borisova, EV; Ostroumova, OD; Pavleeva, EE | 1 |
| Lévy, BI; Taddei, S | 1 |
| Borghi, C; Buda, S; Degli Esposti, L; Gambera, M; Nati, G; Perone, F; Perrone, V; Tagliabue, PF; Veronesi, C | 1 |
| Borisova, EV; Kochetkov, AI; Ostroumova, OD; Ostroumova, TM | 1 |
| Fleig, SV; Haller, H; Limbourg, FP; Weger, B | 1 |
| Dézsi, CA; Farsang, C | 1 |
| Bezuglova, EI; Kornilov, AA; Luneva, YV; Povetkin, SV | 1 |
| Aje, A; Badri, M; Barasa, F; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kana, SS; Kramer, N; Mayosi, BM; Mntla, P; Mondo, C; Ogah, O; Ogola, EN; Ogunbanjo, G; Ojji, DB; Okpechi, I; Poulter, N; Sani, MU; Shedul, G; Sliwa, K; Smythe, W | 1 |
| Dąbek, J; Madej, A; Majewski, M; Szuta, J | 1 |
| Statsenko, ME; Titarenko, MN; Turkina, SV | 1 |
| Laurent, S; Mancia, G; Poulter, N | 1 |
| Borisova, EV; Guseva, TF; Ostroumova, OD; Temirbulatov, II | 1 |
| Gilowski, W; Krysiak, R; Marek, B; Okopień, B | 1 |
| Kobalava, ZD; Tolkacheva, VV; Troitskaya, EA | 1 |
| Psaradellis, E; Rampakakis, E; Rickard, J; Sampalis, JS; Stutz, M | 1 |
| Gilyarevsky, SR; Golshmid, MV; Kuzmina, IM | 1 |
| Lishuta, AS; Privalova, EV | 1 |
| Chazova, IE; Elfimova, EM; Litvin, AY | 1 |
| Drobotya, NV; Guseynova, ES; Morgunov, MN; Torosyan, SS | 1 |
| Douma, S; Kallistratos, MS; Manolis, AJ; Tsioufis, K | 1 |
| Badri, M; Barasa, F; Cornelius, V; Damasceno, A; Dzudie, A; Francis, V; Jones, E; Kramer, N; Mayosi, B; Mondo, C; Ogah, O; Ogola, E; Ojji, DB; Okpechi, IG; Poulter, N; Rayner, B; Sani, MU; Shedul, G; Shedul, GL; Sliwa, K; Smythe, W | 1 |
| Dolan, E; Gupta, AK; O'Brien, E; Poulter, NR; Sever, PS; Whitehouse, A | 1 |
| Borisova, EV; Kochetkov, AI; Ostroumova, OD | 1 |
| Chalmers, J; Cooper, ME; Hamet, P; Harrap, S; Juraschek, SP; Lazo, M; Marre, M; McEvoy, JW; Selvin, E; Wang, D; Williams, B; Woodward, M | 1 |
| van der Merwe, WM | 1 |
| Dehayem, MY; Etoa, M; Hamadou, B; Kaze, FF; Kengne, AP; Kouam, M; Mbanya, JC; Mfeukeu-Kuate, L; Nganou-Gnindjio, CN; Ngassam, E; Nkamgna, A; Sobngwi, E; Tankeu, AT | 1 |
| Dézsi, CA; Simon, A | 1 |
| Andor, M; Baibata, DE; Buda, V; Cheveresan, A; Coricovac, D; Cozlac, R; Danciu, C; Ledeti, I; Nica, C; Radu, G; Tomescu, MC; Tuduce, P | 1 |
| Brown, K; Donato, A | 1 |
| Asmar, R; De Champvallins, M; Feldmann, L; Mourad, JJ; Topouchian, J | 1 |
| Gapon, LI; Kolesnikova, SN; Musikhina, NA; Petelina, TI; Utesheva, AB | 1 |
| Karpov, IuA | 3 |
| Araki, N; Ishigami, T; Kakizoe, Y; Kitamura, K; Maeda, E; Minegishi, S; Tamura, K; Umemura, M; Umemura, S; Ushio-Yamana, H | 1 |
| Nagy, VL | 1 |
| Václavík, J | 1 |
| Beckett, N; Bulpitt, C; Fagard, R; Fletcher, A; Forette, F; Pereira, L; Peters, R; Thijs, L; Wang, JG | 1 |
| Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV | 1 |
| Budagovskaya, ZM; Iskenderov, BG; Sisina, ON | 1 |
| Dinicolantonio, JJ; Lavie, CJ; O'Keefe, JH | 1 |
| Barbarash, OL; Cherniavskaia, EIu; Zvereva, TN | 1 |
| Kobalava, ZhD; Kotovskaia, IuV; Luk'ianova, EA | 1 |
| Baleeva, LV; Galiavi, RA; Galiavich, AS | 1 |
| Ruilope, L; Schaefer, A | 1 |
| Arima, H; Chalmers, J; Harrap, S; Hirakawa, Y; Mancia, G; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Bakris, GL; Yamout, H | 1 |
| Carradice, DP; Maxwell, EL | 1 |
| Gorbat, TV; Netchessova, TA; Shepelkevich, AP | 1 |
| Farsang, C | 2 |
| Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Hungerford, SL; Owen, AM | 1 |
| Tóth, K | 1 |
| Schiffrin, EL | 3 |
| Hankey, GJ; Lacey, B | 1 |
| Helal, F; Lane, ME | 1 |
| Baguet, JP; Bejan-Angoulvant, T; Boivin, JM; Bricca, G; Erpeldinger, S; Fauvel, JP; Gagnol, JP; Giraud, C; Gueyffier, F; Leftheriotis, G; Maucort-Boulch, D; Mercier, A; Subtil, F; Zerbib, Y | 1 |
| Chwallek, F; Pimenta, E; Wang, JG | 1 |
| Holzgreve, H | 3 |
| Anderson, C; Arima, H; Bousser, MG; Chalmers, J; Harrap, S; Liu, L; MacMahon, S; Mancia, G; Neal, B; Omae, T; Tzourio, C; Woodward, M | 1 |
| Alexandre, J; Emile, G; Pujade-Lauraine, E | 1 |
| Dmitrova, TB; Kobalava, ZhD; Kotovskaia, IuV; Luk'ianova, EA; Troitskaia, EA | 1 |
| Balandina, IuA; Maksimchuk-Kolobova, NS; Tarlovskaia, EI | 1 |
| Banya, W; Beckett, N; Bulpitt, C; Duggan, J; Fagard, R; Fletcher, A; Leonetti, G; McCormack, T; Narkiewicz, K; Peters, R; Thijs, L | 1 |
| Cheung, CS; Cheung, NT; Griffiths, SM; Hirai, HW; Kwan, MW; Lao, XQ; Meng, HM; Tam, WW; Tong, EL; Tsoi, KK; Wang, HH; Wong, MC; Yan, BP | 1 |
| Ruilope, L | 1 |
| Fisun, NI; Nazarov, AG; Nechaeva, GI; Novikov, AI; Pritykina, TV; Semenkin, AA; Zhivilova, LA | 1 |
| DiNicolantonio, JJ; O'Keefe, JH | 1 |
| Páll, D; Szabó, Z; Szántó, I | 1 |
| Marcinkowska, J; Posadzy-Malaczynska, A; Rajpold, K; Woznicka-Leskiewicz, L | 1 |
| Arima, H; Billot, L; Chalmers, J; Colagiuri, S; Cooper, ME; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Hirakawa, Y; Joshi, R; Li, Q; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Matthews, DR; Mogensen, CE; Monaghan, H; Neal, B; Patel, A; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Amodeo, C; Asmar, R; Chazova, IE; Gamba, MA; Mancia, G; Mourad, JJ; Puig, JG; Taddei, S | 1 |
| Yang, Z | 1 |
| Chazova, I; Erglis, A; Farsang, C; Laucevicius, A; Laurent, S; Parati, G; Sirenko, Y | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| Gontarenko, SV; Kuz'mina, EP; Morozova, TE | 1 |
| Borghi, C; Cicero, AF; Morbini, M | 1 |
| Budagovskaia, ZM; Iskenderov, BG; Sisina, ON | 1 |
| Krzesinski, JM; Lancellotti, P; Scheen, AJ | 1 |
| Khashieva, FM; Poteshkina, NG | 1 |
| Bakris, GL; Elliott, WJ; Feldstein, JD; Whitmore, J | 1 |
| Kobalava, ZD; Kotovskaya, YV; Tigai, ZG; Villevalde, SV | 1 |
| Bhat, SA; Goel, R; Hanif, K; Nath, C; Rajasekar, N; Shukla, R | 1 |
| Beckett, N; Bulpitt, C; Falaschetti, E; Mitnitski, A; Peters, R; Rockwood, K; Thijs, L; Warwick, J | 1 |
| Chindareva, OI; Nechaeva, GI; Pritykina, TV; Semenkin, AA; Stroeva, TV; Zhenatov, AB; Zhivilova, LA | 1 |
| Kizilirmak, P; Ongen, Z | 1 |
| Mancia, G | 2 |
| Khodorovich, NA; Kobalava, ZD; Kotovskaya, YV | 1 |
| Csajági, E; Major, Z; Pavlik, G; Szauder, I; Ujhelyi, G | 1 |
| Kanorskiĭ, SG | 1 |
| Ahmed, N; Gomez, K; Mansoor, A; Sehmi, J; Sethi, A | 1 |
| Buda, V; Cristescu, C; Suciu, L; Tomescu, MC; Topîrceanu, A; Udrescu, L; Udrescu, M | 1 |
| Khodorovich, NA; Kobalava, ZhD; Kotovskaia, IuV | 1 |
| Elliott, WJ | 1 |
| McCormack, PL; Shirley, M | 1 |
| Deev, AD; Gorbunov, VM; Karpov, YA | 1 |
| Ruilope, LM | 1 |
| D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM | 1 |
| Bianco, HT; Boschcov, P; Brandão, SA; Figueiredo-Neto, AM; Fonseca, FA; Fonseca, HA; Gidlund, M; Izar, MC; Juliano, L; Lins, LC; Monteiro, AM; Povoa, RM | 1 |
| Akçay, M; Aslan, AN; Baştuğ, S; Bozkurt, E; Durmaz, T; Sari, C; Sari, SÖ | 1 |
| Borovkova, NY; Kuznetsova, TE | 1 |
| Borovkov, NN; Borovkova, NJ; Kovaleva, GV; Kuznecova, TE | 1 |
| Ge, J; Guo, Y; Huo, Y; Jin, Y; Li, G; Li, H; Luo, J; Ma, C; Miao, P; Qi, L; Shen, F; Shi, H; Wang, B; Wang, F; Wu, S; Wu, X; Xu, D; Xu, G; Yang, J; Zhao, S | 1 |
| Hu, D; Huang, J; Liao, Y; Sun, Y; Yang, K; Zhao, R | 1 |
| İnce, I; Karasulu, E; Ölçer, A; Ölçer, M | 1 |
| Abdelhady, A; Albow, A; Khader, S; Sinnuqrut, S | 1 |
| Pichler, G; Redon, J | 2 |
| An, C; Chen, A; Hu, Y; Jiang, Y; Li, Q; Lu, L; Niu, C; Shu, L; Yang, Z; Yu, X; Zhou, L | 1 |
| Häckel, A | 1 |
| Einecke, D | 2 |
| Hatala, R; Hatalova, K; Pella, D; Sidlo, R | 2 |
| Filippov, EV; Yakushin, SS | 1 |
| Ostroumova, OD; Zykova, AA | 1 |
| Grammatikou, V; Kallistratos, M; Karagiannis, A; Vlachopoulos, C | 1 |
| Dézsi, CA; Nádházi, Z | 1 |
| Ahmed, M; Al-Wahshi, Y; Al-Zakwani, I; Alanbaei, M; El Tamimi, H | 1 |
| Dézsi, CA; Forster, T | 1 |
| Karpov, YA | 1 |
| Arima, H; Cistulli, PA; Grunstein, RR; Phillips, CL; Serinel, Y; Wong, KH; Yee, BJ | 1 |
| Radchenko, G; Sirenko, Y | 1 |
| Atkins, ER; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Lees, K; Liu, L; Mancia, G; Marre, M; Perkovic, V; Poulter, N; Rodgers, A; Salam, A; Williams, B; Woodward, M | 1 |
| Andor, M; Baibata, DE; Buda, V; Citu, I; Cretu, O; Cristescu, C; Muntean, C; Munteanu, M; Petrescu, L; Tomescu, MC; Voicu, M | 1 |
| Gilyarevskiy, SR | 1 |
| Chumachek, EV; Hripaeva, VJ; Ledyaeva, AA; Nedogoda, SV; Palashkin, RV; Salasyuk, AS; Smirnova, VO; Tsoma, VV | 1 |
| Ostroumova, OD | 1 |
| Deev, AD; Glezer, MG | 1 |
| Fendrikova, AV; Skibitskiy, VV | 1 |
| Glezer On Behalf Of Program Participants, MG | 1 |
| Glezer On Behalf Of The Optimum Program Participants, MG | 1 |
| Dell'Avvocata, F; Lenti, S; Mazza, A; Ramazzina, E; Rigatelli, G; Sacco, AP; Schiavon, L | 1 |
| Guillausseau, PJ; Lameira, D; Mourad, JJ | 1 |
| Grimaldi, A; Katsahian, S; Laurent, S; Molle, D; Tropeano, AI | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Głuszek, J; Jankowska, K | 1 |
| Burnier, M; Hess, O; Lüscher, T; Waeber, B | 1 |
| Aronow, WS | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Clarke, R; Comsa, M; Fletcher, A; Forette, F; Ma, S; Peters, R; Poulter, R; Ritchie, C; Tuomilehto, J; Waldman, A; Walton, I | 1 |
| Mourad, JJ; Waeber, B | 1 |
| Artigou, JY; de Groote, P; Diévart, F; Galinier, M; Habib, G; Hanon, O; Herpin, D; Juillière, Y; Komajda, M; Neuder, Y; Roudaut, R; Trochu, JN | 1 |
| Deinum, J; Thien, T | 1 |
| Harada, M; Inoue, N | 1 |
| Mehlsen, J | 1 |
| Barrios, V; Divison, JA; Escobar, C; Medialdea, F | 1 |
| Anand, S; De Souza, S; Ogilvie, RI; Roy, P | 1 |
| Bendersky, M; Ferdinand, KC; Forcada, P; Grassi, D; Kotliar, C; O'Flaherty, M; Pellizzari, M; Rodriguez, P; Turri, D | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; Kristinsson, A; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Lundberg, GD | 1 |
| Bertrand, M; Deckers, JW; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
| Dijoud, F; Egan, EJ; Gilibert, S; Sassard, J | 1 |
| Aota, Y; Iwasaka, T; Maki, K; Morimoto, S; Sakuma, T | 1 |
| Shi, XY; Xi, GL; Yuan, HB; Zhu, QF; Zou, Z | 1 |
| Anan'ko, IuA; Barbarash, OL; Smakotina, SA; Trubnikova, OA | 1 |
| Leonova, MV | 1 |
| Ferrari, R | 3 |
| Batyraliev, TA; Fettser, DV; Ishlek, M; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Gil Extremera, B | 1 |
| Achimastos, A; Blacher, J; Protogerou, A; Safar, ME; Stergiou, GS | 1 |
| Cass, A; Chalmers, J; Cooper, M; de Galan, BE; Glasziou, P; Grobbee, DE; Hamet, P; Harrap, S; MacMahon, S; Mancia, G; Marre, M; Mogensen, CE; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Williams, B; Woodward, M | 1 |
| Chang, CL; Dahlof, B; Mastorantonakis, S; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Ghiadoni, L; Kardasz, I; Magagna, A; Salvetti, A; Taddei, S | 1 |
| Beckett, N; Bulpitt, C; Clarke, R; Fletcher, A; Forette, F; Peters, R; Poulter, R; Ritchie, C; Tuomilehto, J; Waldman, A; Walton, I | 1 |
| Bodenmann, P; Chapuis, T; Cornuz, J; de Bosset, V; Jaunin-Stalder, N; Marguerat, I; Nanchen, D; Pasche, O | 1 |
| Abramov, D; Cheng, H | 1 |
| Abadir, E; Chalmers, J; Cooper, M; de Galan, B; Du, X; Hamet, P; Harrap, S; Lip, GY; Ninomiya, T; Patel, A; Pillai, A; Poulter, N; Woodward, M | 1 |
| Widimský, J | 2 |
| Banya, W; Beckett, NS; Bulpitt, CJ; Burch, L; Dumitrascu, D; Fletcher, AE; Liu, L; Nikitin, Y; Peters, R; Staessen, JA; Stoyanovsky, V; Wang, JG | 1 |
| Zannad, F | 1 |
| Bi, Y; Billot, L; Bompoint, S; Chalmers, J; Joshi, R; Kengne, AP; Ninomiya, T; Patel, A | 1 |
| Brugts, JJ; Ferrari, R; Simoons, ML | 1 |
| Hayen, A; Irwig, L; Keenan, K; Neal, BC | 1 |
| Askerov, MM | 1 |
| Bahl, VK; Jadhav, UM; Thacker, HP | 1 |
| Galiavich, AS; Galiavich, RA; Khamidullina, AR | 1 |
| Grassi, G; Mancia, G | 2 |
| Le Jeune, S; Mourad, JJ | 2 |
| Brown, MJ; Cockcroft, JR; Dhakam, Z; Mackenzie, IS; McEniery, CM; Wilkinson, IB | 1 |
| Fak, AS; Ozben, B; Papila-Topal, N; Sumerkan, M; Tanrikulu, AM; Toprak, A | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Atkins, N; Caulfield, M; Collier, D; Dicker, P; Dolan, E; McInnes, G; O'Brien, E; Stanton, AV; Thom, S | 1 |
| Baysan, O; Celebi, H; Erinc, K; Hasimi, A; Isik, E; Karaeren, H; Koz, C; Oz, BS; Uzun, M; Yildirim, M; Yokusoglu, M | 1 |
| Beckett, N; Peters, R | 1 |
| Hoshino, J; Hosoi, T; Iwasaki, T; Kawachi, K; Kurabayashi, M; Morishita, K; Nakamura, T; Ohyama, Y; Saito, T; Saito, Y | 1 |
| Cass, A; Chalmers, J; de Galan, BE; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| Nitschmann, S; Rump, LC | 1 |
| Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Chen, JW; Huang, SS; Lin, SJ; Wu, TC | 1 |
| Lane, DA; Lip, GY | 1 |
| Belikova, EA; Gapon, LI; Iuferova, OV; Makhneva, EA; Musikhina, NA; Petelina, TI; Todosiĭchuk, VV | 1 |
| Basiak, M; Buldak, L; Dulawa, A; Madej, A; Okopien, B; Szkrobka, W | 1 |
| Buus, NH; Christensen, KL; Fenger-Grøn, M | 1 |
| Ionescu, DD | 1 |
| Hara, K; Kadowaki, T | 1 |
| Buniatian, ND; Lednev, OA; Sergeev, SV; Zaslavskaia, RM | 1 |
| Anderson, C; Arima, H; Bousser, MG; Chalmers, J; MacMahon, S; Neal, B; Tzourio, C; Woodward, M | 1 |
| Cheng, XM; Chu, WW; Du, M; Li, Y; Ma, SM | 1 |
| Maksimov, ML; Ostroumova, OD; Starodubtsev, AK | 1 |
| Chalmers, J; Colagiuri, S; Grobbee, DE; Hamet, P; Heller, S; Kengne, AP; Marre, M; Neal, B; Pan, CY; Patel, A; Woodward, M; Zoungas, S | 1 |
| Hasegawa, Y; Shimada, K; Yamaguchi, T | 1 |
| Cass, A; Chalmers, J; Cooper, M; Grobbee, D; Hamet, P; Harrap, S; Liu, L; MacMahon, S; Mancia, G; Mogensen, CE; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M; Zoungas, S | 1 |
| Beckett, N; Bulpitt, C; Fletcher, A; Grimley-Evans, J; McCormack, T; Nunes, M; Peters, R; Pinto, E; Potter, J; Swift, C | 1 |
| Bonnin, P; Debbabi, H; Levy, BI | 1 |
| Ghiadoni, L | 2 |
| Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E | 1 |
| Drzewoski, J; Gaciong, Z; Gasowski, J; Grodzicki, T; Kabat, M; Kłoś, J; Wilkins, A | 1 |
| Beckett, N; Bulpitt, C; Burch, L; de Vernejoul, MC; Duggan, J; Fletcher, A; Gil-Extremera, B; Liu, L; Peters, R; Swift, C | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
| Coletta, E; Davies, R; Haddad, H; Leenen, FH; Ruzicka, M; White, R | 1 |
| Linchak, RM | 1 |
| Beardmore, R; Beckett, N; Bulpitt, C; Mitnitski, A; Mt-Isa, S; Peña-Miller, R; Peters, R; Rockwood, K | 1 |
| Gaudouen, Y; Le Jeune, S; Lopez-Sublet, M; Mourad, C; Mourad, JJ; Pirollo, A | 1 |
| Bell, K; Glasziou, P; Hayen, A; Irwig, L; Neal, B | 1 |
| Cappuccio, FP; Caulfield, M; Collier, D; Cruickshank, JK; Dobson, J; Eldridge, S; Feder, G; Gupta, AK; Poulter, NR; Sever, PS | 1 |
| Alexander, J; Beller, E; Chalmers, J; Clarke, P; Glasziou, PP; Patel, A; Poulter, N; Rajmokan, M; Woodward, M | 1 |
| Gogin, EE | 1 |
| Camici, PG; D'amati, G; Donato, L; Fommei, E; Ghione, S; Lombardi, M; Mancini, M; Neglia, D; Parker, H; Pisani, P; Varela-Carver, A | 1 |
| Buniatian, ND; Lednev, OA; Lukashev, AM; Sergeev, SV; Zaslavskaia, RM | 1 |
| Liu, KL; Lo, M; Naelten, G | 1 |
| Bălan, H | 1 |
| Dolan, E; Jin, Y; Li, Y; O'Brien, E; Protogerou, A; Richart, T; Safar, ME; Staessen, JA; Thijs, L; Wang, JG | 1 |
| Angeli, F; Reboldi, G; Verdecchia, P | 1 |
| Anand, S; Tsoukas, G; Yang, K | 1 |
| Banya, W; Beckett, NS; Bulpitt, CJ; Burch, LA; Fagard, R; Fletcher, AE; Gergova, V; Leonetti, G; Peters, R | 1 |
| Kostka-Jeziorny, K; Tykarski, A; Uruski, P | 1 |
| Isikova, KhV; Kobalava, ZhD; Villeval'de, SV | 1 |
| Ruilope, LM; Schaefer, A | 1 |
| Nedogoda, SV | 2 |
| de Leeuw, PW | 2 |
| Hota, N; Kubo, Y; Nunoda, S; Okajima, K; Otsuka, K; Shitakura, K; Takasugi, E; Watanabe, Y | 1 |
| Anderson, C; Arima, H; Chalmers, J; Hata, J; Macmahon, S; Murakami, Y; Neal, B; Omae, T; Woodward, M | 1 |
| Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS | 1 |
| Arima, H; Chalmers, J | 1 |
| Pella, D | 1 |
| Avksent'eva, MV; Mal'chikova, SV; Tarlovskaia, EI | 1 |
| Chumachok, EV; Lediaeva, AA; Mazina, GG; Nedogoda, SV; Salasiuk, AS; Tsoma, VV | 1 |
| Ishmurzin, GP | 1 |
| Hamet, P | 1 |
| Furukawa, M; Hattori, T; Kato, Y; Miyachi, M; Murase, T; Murohara, T; Nagata, K; Ohtake, M; Takahashi, K; Takatsu, M; Tsuboi, K; Yazawa, H | 1 |
| Poulter, NR | 1 |
| Mourad, JJ | 1 |
| Chan, JS; Chenier, I; Filep, JG; Godin, N; Ingelfinger, JR; Liu, F; Lo, CS; Maachi, H; Shi, Y; Zhang, SL | 1 |
| Beckett, N; Bulpitt, C; Dumitrascu, D; Fletcher, A; Forette, F; Gil-Extremera, B; McCormack, T; Peters, R; Potter, J; Sever, P; Staessen, JA; Swift, C; Thijs, L; Tuomilehto, J | 1 |
| Basiak, M; Bołdys, A; Bułdak, L; Labuzek, K; Madej, A; Okopień, B | 1 |
| Li, L; Lu, W; Shang, D; Zhang, T; Zhou, T; Zhou, X | 1 |
| Clavreul, N; Isabelle, M; Ragonnet, C; Sansilvestri-Morel, P; Simonet, S; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
| Beulens, JW; Chalmers, J; Cooper, ME; Grobbee, DE; Harrap, S; Kengne, AP; Mancia, G; Neal, B; Patel, A; Poulter, N; van der Schouw, YT; van Dieren, S; Woodward, M; Zoungas, S | 1 |
| Avolio, AP; Butlin, M; Ng, K | 1 |
| Deev, AD; Karpov, IuA | 2 |
| Belenkov, IuN; Danilogorskaia, IuA; Privalova, EV; Shchendrygina, AA; Zheleznykh, EA | 1 |
| Jackson, SH; Mukhtar, O | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Fagard, R; Fletcher, A; Li, M; Narkiewicz, K; Nitsch, D; Peters, R; Poulter, R; Wang, N | 1 |
| Böhmer, LH; Du Plooy, SH; Du Plooy, WJ; Osuch, E | 1 |
| Drouet, C; Graffin, B; Hosotte, M; Kanny, G; Landy, C; Millot, I; Nadaud, J; Plancade, D; Ragot, C | 1 |
| Golubeva, LV; Logovikova, SI; Protasov, KV; Reshina, IV; Sinkevich, DA; Zhizhko, NV | 1 |
| Kanorskiĭ, SG; Shevelev, VI | 1 |
| Napalkov, DA | 1 |
| Britov, AN; Bystrova, MM; Orlov, AA | 1 |
| Asmar, R; Leenen, F; Myers, MG; Safar, ME | 1 |
| Bicket, DP | 1 |
| Amouyel, P; Asmar, R; Dahlöf, B; De Leeuw, PW; De Simone, G; Degaute, JP; Dubourg, O; García Puig, J; Gosse, P; Guéret, P; Karpov, Y; Le Heuzey, JY; Magometschnigg, D; Matos, L; Nieminen, M; Schmieder, R | 1 |
| Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 2 |
| Asmar, R; Guérin, A; London, G; Pannier, B; Safar, M | 1 |
| Gurevich, MA | 1 |
| Ebzeeva, EIu; Kirichenko, AA | 1 |
| Arabidze, GG; Fishchenko, SG; Ipatov, AI; Tebloev, KI | 1 |
| Anderson, A; Morgan, TO | 1 |
| Bourkaib, R; Ezzaher, A; Herpin, D; Meunier, A; Poterre, M; Ragot, S | 1 |
| Bellido, CA; Costa, M; Forcada, P; Iavícoli, OR; Lerman, J; Piñeiro, DJ; Toblli, JE | 1 |
| Davis, SM; Donnan, GA; Thrift, A | 1 |
| Cao, G; DeRosa, G; Forcada, P; Pagano, P; Piorno, P; Rivas, C; Toblli, JE | 1 |
| Bath, P | 1 |
| Anderson, C | 1 |
| Davis, SM; Donnan, GA | 1 |
| Horie, H; Horie, M; Kinoshita, M; Matsumoto, T; Matsuo, S; Minai, K; Ohira, N; Ozawa, T; Takashima, H; Tarutani, Y; Yasuda, Y | 1 |
| London, GM | 1 |
| Chalmers, J | 3 |
| Agabiti-Rosei, E | 1 |
| Anderson, C; Chalmers, J; Chapman, N; MacMahon, S; Neal, B; Tzourio, C; Woodward, M | 1 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R; Mugellini, A | 1 |
| Borbás, S; Dienes, BS; Farsang, C; Lengyel, M; Zorándi, A | 1 |
| Camici, PG; Deverre, JR; Duboc, D; Hanon, O; Mourad, JJ; Safar, ME; Sellier, P | 1 |
| Hiromi, Y; Kato, K; Kawahara, H; Muraoka, I; Nabeshima, T; Seno, H; Takasu, R; Yamada, S | 1 |
| Allen, TJ; Burns, WC; Burrell, LM; Cao, Z; Cooper, ME; Davis, BJ; Johnston, CI; Kubota, E | 1 |
| Cambien, F; Chalmers, J; Chapman, N; Colman, S; Harrap, SB; Leguennec, S; MacMahon, S; Neal, B; Ohkubo, T; Poirier, O; Raoux, S; Tzourio, C; Woodward, M | 1 |
| Waeber, B | 4 |
| Laurent, S | 3 |
| Ciccarelli, L; Cicero, AF; Derosa, G; Fogari, R | 1 |
| Chalmers, J; MacMahon, S | 1 |
| Adams, HP; Chalmers, J; Donnan, GA; Fox, K; MacMahon, S; Mancia, G; Tzourio, C | 1 |
| Donnan, GA | 1 |
| Negri, AL | 1 |
| Lip, GY; Makin, AJ | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M | 1 |
| Hasegawa, K; Kuji, T; Ogawa, N; Shimura, G; Tochikubo, O; Umemura, S; Yasuda, G | 1 |
| Asmar, RG; London, GM; O'Rourke, MF; Safar, ME | 1 |
| Batchelor, A; Cohn, JN; Dong, V; Julius, S; Lagast, H; Neutel, J; Shen, Y; Turlapaty, P; Weber, M | 1 |
| Batchelor, A; Cohn, JN; Dong, V; Guo, W; Julius, S; Lagast, H; Neutel, J; Shen, Y; Turlapaty, P; Weber, M | 1 |
| Aronow, WS; Frishman, WH | 1 |
| Muir, KW | 1 |
| Abe, Y; Aizawa, Y; Ali, F; Hasegawa, G; Hirabayashi, K; Kodama, M; Ma, M; Nagai, Y; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Shirai, K; Soga, M; Suresh, P; Tachikawa, H; Takahashi, T; Wahed, M; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Asmar, R; Battegay, E; Chamontin, B; De Leeuw, PW; Duprez, D; Hitzenberger, G; Mallion, JM; O'Brien, E; O'Rourke, MF; Rahn, KH; Romero, R; Safar, ME | 1 |
| An, N; Kang, S; Ren, M; Wu, YF | 1 |
| Friesewinkel, O; Furrer, M; Hänggi, G; Rutschmann, A | 1 |
| Duerden, M | 1 |
| Chalmers, J; Chapman, N; Colman, S; Lee, A; Liu, LS; MacMahon, S; Rodgers, A; Woodward, M | 1 |
| Berthet, K; Bousser, MG; Chalmers, JP; Colman, SA; MacMahon, SW; Neal, BC; Woodward, M | 1 |
| Candy, GP; Essop, MR; Hlatshwayo, NM; Kachope, J; Libhaber, CD; Libhaber, EN; Norton, GR; Puane, MO; Sareli, P; Sliwa, K; Woodiwiss, AJ | 1 |
| Anisimova, LP; Ivanenko, VV; Legkiĭ, AV; Lopatin, IuM; Riazantseva, NV; Semenova, NV | 1 |
| Hirata, Y | 1 |
| Matsumoto, M | 1 |
| Asmar, R; Béliveau, R; Burgess, ED; Carrière, S; Conter, HS; Lacourcière, Y; Lepage, S; Pesant, Y; Plante, GE; Spence, JD | 1 |
| Asmar, RG; de Luca, N; London, GM; O'Rourke, MF; Safar, ME | 1 |
| Leenen, FH | 1 |
| Battegay, E; De Leeuw, PW; de Luca, N; Duprez, D; Hitzenberger, G; Mallion, JM; O'Brien, E; O'Rourke, MF; Rahn, KH; Romero, R; Safar, ME; Sever, P; Trimarco, B | 1 |
| Buus, NH; Bøttcher, M; Christensen, KL; Jørgensen, CG; Mulvany, MJ; Nielsen, TT; Thygesen, K | 1 |
| Horký, K | 1 |
| Fedelesová, V; Widimský, J | 1 |
| Brizhan, MV; Butikov, VP; Fisun, AIa; Kuroedov, AV; Mikhaĭlov, AA; Simonenko, VB; Tsokolov, AV | 1 |
| Batchelor, A; Cohn, JN; Guo, W; Julius, S; Lagast, H; Neutel, JM; Shen, Y; Turlapaty, P; Weber, MA | 1 |
| Nakaki, T; Tanaka, K | 1 |
| Iarygina, MA; Kirichenko, LL; Korolev, AP; Masenko, VP; Panchenkova, EA; Rusak, TV; Tseka, OS | 1 |
| Nebieridze, DV; Oganov, RG | 1 |
| Gao, YJ; He, CC; Lee, RM; Li, N; Luo, BH; Su, CJ; Yi, JJ; Zeng, ZH | 1 |
| Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; O'Brien, RC; Raffaele, J; Tsalamandris, C | 1 |
| Wennberg, R; Zimmermann, C | 1 |
| Chalmers, J; Macmahon, S; Neal, B; Rodgers, A | 1 |
| Campbell, DJ; Chalmers, JP; Colman, SA; Jenkins, AJ; Kemp, BE; MacMahon, SW; Neal, BC; Patel, A; Woodward, M | 2 |
| Attia, J; D'Este, C; Levi, CR | 1 |
| Andréjak, M; Duru, G; Laville, M; Mourad, JJ; Waeber, B; Zannad, F | 1 |
| Aytimur, M; Gürgün, C; Nalbantgil, I; Nalbantgil, S; Onder, R; Ozerkan, F; Yilmaz, H; Zoghi, M | 1 |
| Krzesinski, JM | 1 |
| Chetstowski, K; Ciechanowicz, A; Foltynska, A; Goracy, I; Janczak-Bazan, A; Jastrzebskal, M; Naruszewicz, M; Wesotowska, T; Widecka, K | 1 |
| Aparina, TV; Britov, AN; Dilakian, EA; Ektova, TV; Gomazkov, OA; Iakimenko, ON | 1 |
| Gladysheva, EA; Makolkin, VI; Osadchiĭ, KK | 1 |
| Kulschewski, A; Schrader, J | 1 |
| Cockcroft, JR | 2 |
| Chapuis, B; Liu, KL; Lo, M; Naelten, G | 1 |
| Anan, F; Hara, M; Nakagawa, M; Ooie, T; Saikawa, T; Takahashi, N; Yonemochi, H; Yoshimatsu, H; Yufu, K | 1 |
| Bokura, H; Kobayashi, S | 1 |
| Amar, J; Chamontin, B; Ferrières, J; Mallion, JM; Peyrieux, JC; Ruidavets, JB; Safar, ME | 1 |
| Brel', UA; Chaliabi, TA; Kapustin, IO; Marchenko, IV; Nedogoda, SV; Prokhorova, EA; Tsoma, VA | 1 |
| Bavanandan, S; Chandran, A; Ismail, O; Morad, Z; Singaraveloo, M; Thayaparan, T | 1 |
| Campo, G; Ceconi, C; Ferrari, R; Gardini, E; Notarstefano, P; Pasanisi, G | 1 |
| Sun, M; Tao, LJ; Xu, H | 1 |
| Anderson, C; Arima, H; Chalmers, J; Colman, S; Hart, RG; MacMahon, S; Neal, B; Rodgers, A; Woodward, M | 1 |
| Boasquevisque, EM; de Lourdes Rodrigues, M; Francischetti, EA; Genelhu, V; Ismerim, VL; Matos, JP | 1 |
| Mogensen, CE | 1 |
| Dahlöf, B; De Leeuw, PW; de Simone, G; Degaute, JP; Dubourg, O; García-Puig, J; Gosse, P; Guéret, P; Karpov, Y; Magometschnigg, D; Matos, L; Schmieder, R | 1 |
| De Simone, C; Famularo, G; Minisola, G; Nicotra, GC | 1 |
| Hayashi, M; Muranishi, M; Ohara, T; Oiwa, K; Yamamoto, Y | 1 |
| Brel', UA; Chaliabi, TA; Marchenko, IV; Nedogoda, SV; Prokhorova, EA; Tsoma, VV | 1 |
| Füessl, HS | 1 |
| Beckett, N; Bulpitt, C; Peters, R; Pinto, E; Rajkumar, C; Staessen, JA | 1 |
| Collier, D; Cruickshank, K; Hughes, AD; Lacy, PS; O'Rourke, M; Stanton, A; Thom, SM; Thurston, H; Williams, B | 1 |
| Ciliberti, P; Graziosi, M; Rapezzi, C; Riva, L | 1 |
| Jiang, QJ; Mao, FF; Xu, G; Zhu, YF | 1 |
| Brezniceanu, ML; Chan, JS; Filep, JG; Guo, DF; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Liu, Q; Sachetelli, S; Sigmund, CD; Zhang, SL | 1 |
| Bartosz, G; Czuczejko, J; Kedziora, J; Kedziora-Kornatowska, K; Kornatowski, T; Pawluk, H; Szadujkis-Szadurski, L | 1 |
| Kirkpatrick, PJ; Turner, CL; Wilkinson, IB | 1 |
| Baba, S; Hosozawa, KI; Ikeda, K; Iwasaki, Y; Kashihara, H; Tamura, M | 1 |
| Balkestein, E; Boutouyrie, P; Joannides, R; Katsahian, S; Laloux, B; Laurent, S; Pannier, B; Struijker-Boudier, H; Thuillez, C; Tropeano, AI | 1 |
| Alekhin, MN; Chumakova, OS; Larina, VN; Sidorenko, BA; Timofeeva, LA; Ugriumov, MO | 1 |
| Gosse, P | 1 |
| Boutouyrie, P; Laurent, S; Tropeano, AI | 1 |
| Ruilope, LM; Segura, J | 1 |
| Bakhshaliev, AB; Sabzalieva, GM | 2 |
| Deev, AD; Karpov, IuA; Shal'nova, SA | 1 |
| Bugriĭ, ME; Chazova, IE; Gornostaev, VV; Mychka, VB; Sergienko, VB | 1 |
| Czuczejko, J; Kedziora, J; Kedziora-Kornatowska, K; Kornatowski, T; Motyl, J; Pawluk, H; Szadujkis-Szadurski, L; Szewczyk-Golec, K | 1 |
| Dzhanaridze, LU; Mamaladze, GT; Megreladze, II; Pagava, ZT; Sadunishvili, MZ | 1 |
| Laville, M; Mourad, JJ | 1 |
| Waeber, B; Zanchetti, A | 1 |
| Chalmers, J; Joshi, R; Patel, A; Perkovic, V | 1 |
| Holzgreve, H; Risler, T; Trenkwalder, P | 1 |
| Hasegawa, Y | 1 |
| Fournier, A; Safar, ME | 1 |
| Leenen, FH; Myers, MG | 2 |
| Janczak-Bazan, A | 1 |
| De la Figuera von Wichmann, M; Llisterri Caro, JL | 1 |
| Tubek, S | 2 |
| Ismail, SB; Naing, L; Rahman, AR; Rehman, A; Roshan, TM | 1 |
| Safar, ME | 1 |
| Brady, AJ | 1 |
| Campbell, DJ | 1 |
| Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
| Bompoint, S; Chalmers, J; Joshi, R; Patel, A; Perkovic, V | 1 |
| Bartolome, M; Dans, AL; Flor, B; Mendoza, VL; Ragual, J; Rellama-Black, S; Tumanan-Mendoza, BA; Valdez, J; Villacin, LL | 1 |
| Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
| Guo, Q; Ito, O; Kanazawa, M; Kawamura, T; Kohzuki, M; Kurosawa, H; Li, Y; Minami, N; Mori, N; Nagasaka, M; Ogawa, M | 1 |
| Chalmers, J; Joshi, R; Kengne, AP; Patel, A; Perkovic, V | 1 |
| Lopez-Sublet, M; Mourad, JJ; Nguyen, V; Waeber, B | 1 |
| Rahn, KH | 1 |
| Ambrosioni, E; Holzgreve, H; Laurent, S; Mancia, G; Ruilope, LM; Struijker-Boudier, HA; Waeber, B | 1 |
| Kaplan, NM | 1 |
| Billot, L; Chalmers, J; Cooper, M; Glasziou, P; Grobbee, DE; Hamet, P; Harrap, S; Heller, S; Liu, LS; MacMahon, S; Mancia, G; Marre, M; Mogensen, CE; Neal, B; Pan, CY; Patel, A; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
| Nagy, V | 2 |
| Leye, A; Marre, M | 1 |
| Asmar, R; De Leeuws, PW; Garcia-Puig, J; Gosse, P; Karpov, YA; Magometschniggs, D; Matos, L; Schmieder, R | 1 |
| Begg, DP; Chen, N; Jayasooriya, AP; Mathai, ML; Sinclair, AJ; Wark, JD; Weisinger, HS; Weisinger, RS; Wilkinson-Berka, J | 1 |
| Inzhutova, AI; Petrova, MM; Salmina, AB | 2 |
| Dmitriev, VA; Masenko, VP; Oshchepkova, EV; Rogoza, AN; Titiov, VN | 1 |
| Dahlof, B; Dobson, J; Gupta, AK; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Feihl, F; Heim, A; Waeber, B | 1 |
| Statsenko, ME; Zemlianskaia, MM | 1 |
| Durina, J; Kratochvíl'ová, H; Remková, A | 1 |
| Chalmers, J; Joshi, R; Patel, A | 1 |
| Cochain, C; Duriez, M; Lévy, BI; Loinard, C; Mees, B; Silvestre, JS; Vilar, J; You, D | 2 |
| Bakris, GL; Berkwits, M | 1 |
| Bugnicourt, JM; Canaple, S; Chillon, JM; Godefroy, O; Lamy, C | 1 |
| Benzoni, D; Issiakhem, M; Liu, KL | 1 |
| Anderson, C; Antikainen, RL; Banya, W; Beckett, NS; Belhani, A; Bulpitt, CJ; Dumitrascu, D; Fletcher, AE; Forette, F; Liu, L; Nikitin, Y; Peters, R; Rajkumar, C; Staessen, JA; Stoyanovsky, V; Thijs, L | 1 |
| Cohen, R; Emonnot, L; Lo, M | 1 |
| Abeel, M; Bellien, J; Iacob, M; Joannides, R; Thuillez, C; Thurlure, C | 1 |
| Chalmers, J; Doney, A; MacMahon, S; Macwalter, R; Pumford, N; Tavakoli, M; Woodward, M | 1 |
| Martynov, AI; Obukhov, AA; Sharkova, NE | 1 |
| Chen, JW; Lin, SJ; Sung, SH; Wu, TC | 1 |
| Acikel, C; Baysan, O; Celik, M; Celik, T; Isik, E; Iyisoy, A; Yaman, H; Yuksel, C | 1 |
| Hönl, SB | 1 |
| Aalkjaer, C; Holm, M; Lederballe, O; Mulvany, M; Mørn, B; Schroeder, AP; Sihm, I; Thygesen, K | 2 |
| Heagerty, AM; Kolloch, RE; Ludwig, M; Mancia, G; Safar, M; Stumpe, KO; Zanchetti, A | 2 |
| Kool, MJ; Spek, JJ; Van Bortel, LM | 1 |
| Gohlke, P; Unger, T | 1 |
| Amin, F; Atkinson, J; Makki, T; Niederhoffer, N; Tankosic, P; Tatchum-Talom, R | 1 |
| Filatova, NP | 1 |
| Dzúrik, R; Fedelesová, V; Gajdos, M; Oksa, A; Spustová, V | 1 |
| Krone, W; Middeke, M | 1 |
| Bartenbach, S; Gohlke, P; Kuwer, I; Schnell, A; Unger, T | 1 |
| Fedelesová, V; Uhlír, O; Widimský, J | 1 |
| Campbell, AM; Clark, JS; Davidson, AO; Devlin, AM; Dominiczak, AF; Gordon, JF; Hamilton, CA; Morton, JJ; Reid, JL | 1 |
| Delaney, KH; Lee, RM; Lu, M | 1 |
| Lamote, J; Sennesael, J; Tasse, S; Verbeelen, D; Violet, I | 1 |
| Aalkjaer, C; Cooper, A; Heagerty, AM; Mulvany, MJ; Stephens, N; Thybo, NK | 1 |
| Cooper, ME; Doyle, AE; Rumble, JR | 1 |
| Carlier, P; Ciancabilla, F; Rorive, G; Smelten, N | 1 |
| Gallois, H; Le Coz, Y; Ollivier, JP; Revel, F; Richard, R | 1 |
| Koanantakul, B; Ngam-Ukos, P; Ratanaprakarn, R; Sukonthasarn, A | 1 |
| Tarentini Trojani, F | 1 |
| Denolle, T; Poggi, L; Renucci, JF | 1 |
| Plante, GE | 1 |
| Aalkjaer, C; Holm, M; Mulvany, M; Mørn, B; Pedersen, OL; Schroeder, AP; Sihm, I; Thygesen, K | 1 |
| Lee, RM; Smeda, JS; Wang, H | 2 |
| Antony, I; Lerebours, G | 1 |
| Anderson, A; Morgan, O; Morgan, T | 1 |
| Adamczak, M; Bachmann, W; Bönner, G; Bretzel, RG; Derichs, R; Krone, W; Lederle, RM; Overlack, A; Reimann, HJ; Zschiedrich, H | 1 |
| Bayata, S; Postaci, N; Yeşil, M; Yeşil, S | 1 |
| Christensen, KL; Mulvany, MJ | 1 |
| Breed, JG; Hoeks, AP; Kool, MJ; Lustermans, FA; Struyker-Boudier, HA; Van Bortel, LM | 1 |
| Christensen, KL; Eriksen, S; Korsgaard, N; Mulvany, MJ; Thybo, NK | 1 |
| Agnes, E; Desche, P; Letellier, P; Overlack, A | 1 |
| Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G | 1 |
| Black, MJ; Campbell, GR; Campbell, JH | 1 |
| Berrut, G; Fressinaud, P; Marre, M; Suraniti, S | 1 |
| Overlack, A; Stumpe, KO | 2 |
| Devissaguet, M; Levy, BI; Michel, JB; Poitevin, P; Safar, ME; Salzmann, JL; Scalbert, E | 1 |
| Head, GA; Minami, N | 3 |
| Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Schnell, A; Unger, T | 1 |
| Casley, DJ; Doyle, AE; Harrap, SB; Mirakian, C; Mitchell, GA | 1 |
| Barden, PL; Chrysant, SG; McDonald, RH; Weiss, RJ; Wright, JT | 1 |
| Berrut, G; Fressinaud, P; Gallois, H | 1 |
| Alcocer, L; Bahena, JH; Calvo, C; Campos, C; Lerebours, G; Mickalonis, L; Nacaud, A; Parra Carillo, J; Villahermosa, MT; Weber, C | 1 |
| Breed, JG; Hoeks, AP; Kool, MJ; Lustermans, FA; Reneman, RS; Struyker Boudier, HA; Van Bortel, LM | 1 |
| Chauvin, B; Giudicelli, JF; Richer, C | 1 |
| Anderson, A; Morgan, O; Morgan, TO | 1 |
| Chen, X; Dai, Z; Hui, Y; Wang, W | 1 |
| Campbell, DJ; Duncan, AM; Harrap, SB; Kladis, A | 1 |
| Alivanis, P; Dioudis, C; Goutsaridis, N; Grekas, D; Kalevrosoglou, I; Papoulidou, F; Tourkantonis, A | 1 |
| Anderson, NH; Bohr, DF; Devlin, AM; Dominiczak, AF; Lee, WK; Reid, JL | 1 |
| Bignotti, M; Gaudio, G; Grandi, AM; Guasti, L; Venco, A; Zanzi, P | 1 |
| Bennett, MA; Hillier, C; Thurston, H | 1 |
| Andonova, K; Borissova, AM; Orbetzova, M; Sheitanova, S; Torbova, S; Zacharieva, S | 1 |
| Alivanis, P; Derveniotis, V; Dioudis, C; Grekas, D; Kalevrosoglou, I; Tourkantonis, A | 1 |
| Bienz, R; Böhlen, L; Doser, M; Papiri, M; Riesen, W; Shaw, S; Weidmann, P | 1 |
| Benzoni, D; Liu, KL; Sassard, J | 1 |
| Clementy, J; Gosse, P | 1 |
| Harrap, SB; O'Sullivan, JB | 1 |
| Franco-Saenz, R; Mulrow, PJ; Tokita, Y | 1 |
| Mulvany, MJ | 1 |
| Brault, Y; Chastang, C; Di Perri, T; Guez, D; Laurandin, I; Luccioni, R; Redon, J; Sever, PS | 1 |
| Asmar, R; Benetos, A; Cambien, F; Gautier, S; Lacolley, P; Laurent, S; Poirier, O; Ricard, S; Safar, M; Topouchian, J | 1 |
| Guez, D; Henry, JP; Joannides, R; Mace, B; Mulder, P; Richard, V; Schiavi, P; Thuillez, C | 1 |
| Hayakawa, H; Raij, L | 1 |
| Chrysant, SG | 1 |
| Dyker, AG; Grosset, DG; Lees, K | 1 |
| Bramich, C; Di Nicolantonio, R; Lan, L; Morgan, TO | 1 |
| Myers, MG | 1 |
| Black, MJ; Bobik, A; Kanellakis, P | 1 |
| Delaney, KH; Kwiecien, JM; Lee, RM; Smeda, JS; Wang, H | 1 |
| Gillies, L; Lee, RM; Lu, M; Werstiuk, ES | 1 |
| Abraham, AA; Michaelis, OE; Scalbert, E; Striffler, JS; Thibault, N; Velasquez, MT | 1 |
| Lantelme, P; Lo, M; Luttenauer, L; Sassard, J | 1 |
| Cao, Z; Cooper, ME; van Geenen, RC; Voskuil, M; Wookey, PJ; Wu, LL | 1 |
| Cholewa, M; Cwetsch, A; Kamiński, G; Kubik, L; Skrobowski, A | 1 |
| Baud, FJ; Bekka, R; Borron, SW; Lapostolle, F | 1 |
| Berman, K; Campbell, DJ; Monaghan, JC; Ryan, M; Stokes, GS | 1 |
| Moulopoulos, S; Stamatelopoulos, S; Zakopoulos, N | 1 |
| Bobrie, G; Chatellier, G; d'Yvoire, MB; Dubroca, I; Dutrey-Dupagne, C; Elkik, F; Menard, J; Vaisse, B; Vaur, L | 1 |
| Anderson, WP; Bergström, G; Johansson, I; Kett, MM; Stevenson, KM | 1 |
| Giannattasio, C; Girerd, X; Laurent, S; Mancia, G; Moulin, C; Safar, M | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R | 1 |
| Gol'dberg, GA; Ivanova, IV; Nesterov, IuI | 1 |
| Poggi, L; Speirs, C; Wagniart, F | 1 |
| Cerutti, C; Ducher, M; Lantelme, P; Lo, M; Paultre, CZ | 1 |
| Head, GA; Thomas, CJ; Woods, RL | 1 |
| Dratwa, M; Lachaud-Pettiti, V; Meyrier, A; Sennesael, J | 1 |
| Bhathena, SJ; Campbell, JD; Hansen, CT; Michaelis, OE; Scalbert, E; Striffler, JS; Thibault, N; Velasquez, MT | 1 |
| Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Gillies, LK; Lee, RM; Werstiuk, ES | 1 |
| Gol'dberg, GA; Nesterov, IuI | 1 |
| Belaia, OL; Gaĭdamakina, NE; Gavrilova, EN; Kakhnovskiĭ, IM; Markov, IE; Markova, ZS; Sivkov, AS; Sivkov, SI | 1 |
| Chen, HC; Jones, M; Kohner, EM; Patel, V; Rassam, SM | 1 |
| Li, Y; Wang, Z; Zhou, Y | 1 |
| Benzoni, D; Bernard, N; Le Roy, AL; Messer-Létienne, I | 1 |
| Anderson, NH; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; Morton, JJ; Reid, JL; Schork, NJ | 1 |
| Heller, J; Hellerová, S | 1 |
| Baumbach, GL; Chillon, JM | 2 |
| Bernaud, CM; Fay, R; Zannad, F | 1 |
| Forette, B | 1 |
| Eliseev, OM | 1 |
| Arnolda, LF; Bune, AJ; Chalmers, JP; Gabb, GM; Harvey, PJ; Molloy, D; Upton, J; Wing, LM | 1 |
| Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
| Sami, M | 1 |
| Brosnan, MJ; Clark, JS; Devlin, AM; Dominiczak, AF; Mullins, JJ | 1 |
| Markham, A; McClellan, KJ | 1 |
| Hughes, AD; Ibrahim, J; Schachter, M; Sever, PS | 1 |
| Castaigne, A; Chalmers, J; Chastang, C; Feldmann, L; Guez, D; Morgan, T | 1 |
| Fukuzawa, A; Ishigai, Y; Mori, T; Moriyama, S; Shibano, T | 1 |
| Rafee, NM; Razak, TA; Yusof, N; Yusoff, K | 1 |
| Elisaf, MS; Kalaitzidis, R; Katopodis, K; Papagalanis, N; Pappas, H; Siamopoulos, KC; Theodorou, J | 1 |
| Leenen, FH; Tan, KW | 1 |
| Altun, B; Arici, M; Cağlar, S; Erdem, Y; Haznedaroğlu, IC; Turgan, C; Usalan, C; Yasavul, U | 1 |
| Donnan, PT; Lim, PO; MacDonald, TM | 1 |
| Cicutti, N; Guez, D; Maurin, A; Rakusan, K; Schiavi, P | 1 |
| Chastang, C; Mallion, JM; Unger, P | 1 |
| Conway, EL; Dawson, M; Louis, WJ; Mander, AG; O'Callaghan, C | 1 |
| Iwao, H; Izumi, Y; Kim, S; Zhan, Y | 1 |
| Asmar, R; Leenen, FH; Myers, MG; Safar, M | 1 |
| Castaigne, A; Chalmers, J; Chastang, C; Morgan, T | 1 |
| Lantelme, P; Lo, M; Sassard, J | 1 |
| Liang, Q; Tang, J; Wu, C; Zhou, Q | 1 |
| Henrion, D; Lévy, BI; Matrougui, K | 1 |
| Leenen, FH; McNally, CF; Tanner, J | 1 |
| Chiang, YF; Lee, YJ; Tsai, JC | 1 |
| Aksoy, FG; Garcia, MJ; Muderrisoglu, H; Sabah, I; Thomas, JD; Yalçin, F | 1 |
| Blain, A; Blain, H; Christophe, P; Tréchot, P | 1 |
| Chen, D; Lin, J; Wu, K | 2 |
| Brehm, M; Mundhenke, M; Schwartzkopff, B; Strauer, BE | 1 |
| Balazovjech, I; Lánská, V; Widimský, J | 1 |
| Glasser, SP | 1 |
| Kuperstein, R; Sasson, Z | 1 |
| Kratochvílová, H; Remková, A | 1 |
| Iwao, H; Izumi, Y; Kim, S; Yano, M; Yasumoto, H; Zhan, Y | 1 |
| Bolster, A; Dyker, AG; Lees, KR; Walters, MR | 1 |
| Chen, DG; Chen, SC; Rui, HB; Su, JZ; Wang, HJ; Wang, XY; Wu, KG | 1 |
| Beckett, N; Bulpitt, C; Coope, J; Fletcher, A; Forette, F; Gil-Extremera, B; Nachev, C; Potter, J; Sever, P; Staessen, J; Swift, C; Tuomilehto, J | 1 |
| Florin, M; Liu, KL; Lo, M; Sassard, J | 1 |
| Bertram, JF; Black, MJ; Johnston, CI | 1 |
| Asmar, R; Benetos, A; Pannier, B; Safar, M; Topouchian, J | 1 |
| Hurst, M; Jarvis, B | 1 |
| Chanudet, X; De Champvallins, M | 1 |
| Cheer, SM; Goa, KL; Matheson, AJ | 1 |
| Dart, AM; McGrath, B; Reid, CM | 1 |
| Chalmers, JP | 1 |
| Dimitrow, PP; Jasiński, T; Pieniazek, W | 1 |
| Paull, JR; Widdop, RE | 1 |
| Bilge, M; Eryonucu, B; Güler, N; Güntekin, U | 1 |
| Fomina, IG; Gaĭdamakina, NE; Georgadze, ZO; Matveev, VV; Nagieva, AZ; Sinitsyna, MG | 1 |
| Staessen, JA; Wang, J | 1 |
| Oparil, S | 2 |
| Sica, DA | 1 |
| McVeigh, GE | 1 |
| Clark, LT | 1 |
| Franczuk, P; Janicki, K; Pieniazek, W | 1 |
| Asmar, RG; London, GM; O'Rourke, ME; Safar, ME | 1 |
| Ol'binskaia, LI; Zheleznykh, EA | 1 |
| Furukawa, T; Ishigai, Y; Isshiki, T; Kawamura, Y; Sato, T; Shibano, T; Takeshita, S; Tomiyama, H; Yokoyama, N | 1 |
| Beevers, G; Caulfield, M; Collins, R; Dahlöf, B; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
| Lee, YJ; Tsai, JC | 1 |
| Bilous, RW; Cordonnier, DJ; Pinel, N; White, KE | 1 |
| Gálvez, A; Jalil, JE; Lavandero, S; Ocaranza, MP | 1 |
| Girerd, X | 1 |
| Upton, MN | 1 |
| Cates, C | 1 |
| D'Ambrosio, M | 1 |
| Cruickshank, J | 1 |
| Andrejak, M; Choukroun, G; Fournier, A; Godefroy, O; Mazouz, H | 1 |
| Beevers, DG; Lip, GY | 1 |
| Masson, C | 1 |
| Scheen, AJ | 1 |
| Beyer, J; Bockisch, A; Frank, M; Kopf, D; Lehnert, H; Schmitz, H | 1 |
| Asmar, RG; Battegay, E; Bénétos, A; Chastang, C; De Leeuw, PW; de Luca, N; Duprez, D; Fitzgerald, D; Hedner, T; Hitzenberger, G; London, GM; Mallion, JM; O'Rourke, ME; Ollivier, JP; Polónia, P; Rahn, KH; Romero, R; Safar, ME; Sever, P; Trimarco, B | 1 |
| Doucet, J; Guez, D; Henry, JP; Mulder, P; Richard, V; Schiavi, P; Thuillez, C | 1 |
| He, FJ; MacGregor, GA | 1 |
| Domergue, V; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C; Trabold, F | 1 |
| Guerin, AP; London, GM; Marchais, SJ; Pannier, BM | 1 |
| Chalmers, J; Chapman, N | 1 |
| Ito, T; Minami, S; Miyazaki, H; Mochizuki, S; Okazaki, F; Onodera, T; Seki, S; Taniguchi, I; Taniguchi, M | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG | 1 |
| Conway, EL; Drummer, O; Harris, G; Jarrott, B; Louis, WJ; McNeil, JJ; Rowley, K; Workman, BS; Worland, P | 1 |
| Ali, A; Desche, P; Dratwa, M; Genissel, P; Resplandy, G; Sennesael, J; Slovic, D; Sweny, P; Vandenburg, M | 1 |
| Anderson, A; Morgan, T | 1 |
| Thurston, H | 2 |
| Bert, P; Breuil, V; Forette, F | 1 |
| Cihák, R; Fedelesová, V; Lefflerová, K; Mayer, O; Uhlír, O; Widimský, J | 1 |
| Allen, TJ; Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC; Rumble, JR | 1 |
| Borgies, P; Brichard, SM; Colin, I; Hermans, MP; Ketelslegers, JM; Lambert, AE | 1 |
| Bak, JF; Gerdes, LU; Pedersen, O; Sørensen, NS | 1 |
| Anderson, AI; Bartholomeusz, LC; Cameron, DP; Conway, EL; Donnelly, T; Frewin, DB; Hooper, MJ; Louis, WJ; MacDonald, GJ; Morgan, TO | 1 |
| Agabiti-Rosei, E; Ambrosioni, E; Finardi, G; Folino, P; Gambassi, G; Malini, P; Marchesi, E; Muiesan, ML; Pessina, AC; Semplicini, A | 1 |
| Degaute, JP; Desche, P; Leeman, M | 1 |
| Depoorter, JC; Herbaut, C; Jandrain, B; Voorde, KV | 1 |
| Gabbani, S; Galeone, F; Giuntoli, F; Natali, A; Saba, P | 1 |
| Abdon, D; Devissaguet, M; Juggi, JS; Scalbert, E | 1 |
| Andresen, J; Mulvany, MJ; Persson, AE | 1 |
| Andrejak, M; Carré, A; Deruyttere, M; Gotzen, R; Magometschnigg, D; Santoni, JP; Stumpe, KO | 1 |
| Abdel-Haq, B; Favilla, S; Magagna, A; Salvetti, A | 1 |
| Desche, P; Devissaguet, M; Levy, B; Safar, ME; Scalbert, E | 1 |
| Asmar, RG; London, GM; Pannier, BM; Safar, ME | 2 |
| Baguet, F; Dratwa, M; Lameire, N; Lins, RL; Sennesael, J; Suc, JM; Taillard, F | 1 |
| Desche, P; Thurston, H | 1 |
| Buckley, MG; MacGregor, GA; Markandu, ND; Miller, MA; Sagnella, GA; Singer, DR | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL | 3 |
| Devissaguet, M; Levy, BI; Michel, JB; Safar, ME; Salzmann, JL | 1 |
| Christensen, KL | 1 |
| Adams, MA; Bobik, A; Head, GA; Minami, N | 1 |
| Barzizza, F; Finardi, G; Folino, P; Grandi, AM; Marchesi, E; Perani, G; Petrucci, E; Scalise, F; Venco, A | 1 |
| Asmar, RG; Safar, ME; Thomas, JR | 1 |
| Atkinson, J; Bray, L; Burlet, C; Capdeville, C; Janian, P; Lartaud, I; Muller, F | 1 |
| Atkinson, J; Bray, L; Capdeville, C; Lartaud, I; Muller, F | 1 |
| Giudicelli, JF; Richard, C; Richer, C; Thuillez, C | 1 |
| Alhenc-Gélas, F; Battaglia, C; Corvol, P; Plouin, PF | 1 |
| Backhouse, CI; Brown, CL; Grippat, JC; Santoni, JP | 1 |
| Barrès, C; Julien, C; Lo, M; Sassard, J; Vincent, M | 1 |
| Michel, JB | 1 |
| Creytens, G; Rorive, G; Ruhwiedel, M; Van de Voorde, K | 1 |
| Griffin, SA; Harrap, SB; Lever, AF; Macpherson, F; Van der Merwe, WM | 1 |
| Brichard, SM; Ketelslegers, JM; Lambert, AE; Santoni, JP; Thomas, JR; Van de Voorde, K | 1 |
| Brown, CL; Creytens, G; Mimran, A; Rorive, G; Santoni, JP; Thurston, H; Zanchetti, A | 1 |
| Asmar, RG; Benetos, A; Daou, J; Laurent, ST; Pannier, B; Safar, M | 1 |
| Brown, CL | 1 |
| Lees, KR | 1 |
| Levy, BI; Michel, JB | 1 |
| Littler, W | 1 |
| Brichard, S; Lambert, AE | 1 |
| Zanchetti, A | 1 |
| Anderson, A; Morgan, T; Murphy, J; Nowson, C; Wilson, D | 1 |
| Barthelmebs, M; Devissaguet, M; Imbs, JL | 2 |
| Hughes, DM; Lees, KR; McNeill, CA; Reid, JL | 2 |
| Frances, Y; Gass, R; Gilgenkrantz, JM; Luccioni, R | 2 |
| Asmar, RG; Bizot-Espiard, JG; Safar, M; Santoni, JP | 1 |
| Brichard, S; Ketelslegers, JM; Lambert, AE | 2 |
| Desche, P; Zanchetti, A | 2 |
| Bouchacourt, P; Delesalle, MC; Forette, F; Henry-Amar, M; Hervy, MP; McClaran, JM; Santoni, JP | 1 |
| Brown, C; Castaings, C; Pouyollon, F; Richard, C; Santoni, JP | 2 |
| Christensen, KL; Jespersen, LT; Mulvany, MJ | 1 |
| Guedon, J | 1 |
| Littler, WA; Smith, SA; Stallard, TJ; West, JN | 1 |
| Herpin, D; Hosie, J; Lees, KR; Reid, JL; Santoni, JP; Scott, MG | 1 |
| Buzzacarini, F; Casolino, P; Marzola, M; Mozzato, MG; Pessina, AC; Rubino, N; Samà, B; Semplicini, A | 1 |
| Bizot-Espiard, JG; Brown, C; Santoni, JP | 1 |
| Asmar, R; Safar, ME; Santoni, JP | 1 |
| Bouchacourt, P; Delesalle, MC; Forette, F; Henry-Amar, M; Hervy, MP; McClaran, J; Santoni, JP | 1 |
| Asmar, RG; Laurent, S; Levy, BI; London, GM; Pannier, B; Safar, ME; Santoni, JP | 1 |
| Barres, C; Cerutti, C; Paultre, CZ; Sassard, J | 1 |
| Ganten, D; Lang, RE; Moursi, MG; Unger, T | 1 |
| Doussau, MP; Giudicelli, JF; Richer, C | 1 |
| Ganten, D; Lang, RE; Lebrun, C; Moursi, MG; Unger, T | 1 |
| Lees, KR; Reid, JL | 1 |
| Frances, Y; Gass, R; Luccioni, R; Perret, L; Santoni, JP; Schwab, C | 1 |
| Ayad, M; Barrou, Z; Chaignon, M; Guédon, J | 1 |
| Azizi, M; Camilleri, JP; Levy, BI; Michel, JB; Poitevin, P; Safar, ME; Salzmann, JL | 1 |
| Baandrup, U; Christensen, HR; Christensen, KL; Jespersen, LT; Mulvany, MJ; Nielsen, H | 1 |
| Asmar, RG; Billaud, E; Journo, HJ; Lacolley, PJ; Levy, BI; Safar, ME; Santoni, JP | 1 |
| Aubert, P; Ayad, M; Barrou, Z; Chaignon, M; Guedon, J; Lucsko, M; Perret, L | 1 |
| Asmar, RG; Pannier, BM; Safar, ME; Santoni, JP | 1 |
| Asmar, RG; London, GM; Pannier, BM; Safar, ME; Santoni, JP | 1 |
123 review(s) available for perindopril and Blood Pressure, High
| Article | Year |
|---|---|
Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2022 |
Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Treatment Outcome | 2022 |
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2023 |
Antihypertensive effect of telmisartan versus perindopril in hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Essential Hypertension; Humans; Hypertension; Perindopril; Telmisartan | 2023 |
Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Kidney Diseases; Observational Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2020 |
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Metabolic Syndrome; Middle Aged; Obesity; Perindopril; Treatment Outcome | 2021 |
[Fixed-Drug Combination Amlodipine, Indapamide and Perindopril: New Horizons of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension; Indapamide; Perindopril | 2017 |
The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke; Treatment Outcome | 2017 |
[Lipertance® The ASCOT single-pill combination has finally arrived].
Topics: Amlodipine; Atorvastatin; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Perindopril; Risk Factors | 2017 |
Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Cough; Dose-Response Relationship, Drug; Drug Combinations; Edema; Humans; Hypertension; Perindopril | 2018 |
Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
Topics: Antihypertensive Agents; Blood Circulation; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2018 |
[Perindopril in the treatment of hypertension and cardiovascular diseases: evolution continues with the orodispersible dosage form].
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Perindopril | 2013 |
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cardiovascular System; Coronary Disease; Heart Failure; Humans; Hypertension; Myocardial Infarction; Perindopril; Ramipril | 2013 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Perindopril; Preventive Health Services; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2014 |
[Principles of choice of an angiotensin-converting enzyme inhibitor: specific features of perindopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbohydrate Metabolism; Cognition; Endothelium, Vascular; Humans; Hypertension; Lipid Metabolism; Perindopril; Renin-Angiotensin System | 2014 |
Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Drug Combinations; Humans; Hypertension; Perindopril | 2015 |
[ADVANCE-ON Trial; How to Achieve Maximum Reduction of Mortality in Patients With Type 2 Diabetes].
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Survival Rate | 2015 |
Prestalia--another combination for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Perindopril | 2015 |
Perindopril/amlodipine (Prestalia(®)): a review in hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Drug Interactions; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic | 2015 |
The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Diuretics; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Lipoproteins, LDL; Male; Middle Aged; Perindopril; Propanolamines; Prospective Studies; Risk Factors | 2016 |
[The Role of the Three-Drug Combination Antihypertensive in Improving the Treatment of Arterial Hypertension].
Topics: Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2017 |
Treatment of heart failure with preserved systolic function.
Topics: Adrenergic beta-Antagonists; Adult; Aged, 80 and over; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Benzopyrans; Blood Pressure; Cardiotonic Agents; Digoxin; Ethanolamines; Heart Failure; Heart Rate; Humans; Hypertension; Myocardial Ischemia; Nebivolol; Perindopril; Randomized Controlled Trials as Topic; Registries; Renal Artery Obstruction; Systole; Treatment Outcome | 2008 |
Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Enalapril; Humans; Hypertension; Lisinopril; Models, Statistical; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2009 |
Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery Disease; Drug Combinations; Female; Humans; Hypertension; Male; Perindopril; Practice Guidelines as Topic | 2008 |
[Innovations in ambulatory care].
Topics: Acute Disease; Age Factors; Aged, 80 and over; Algorithms; Ambulatory Care; Analgesics; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents; Antihypertensive Agents; Depression; Fibromyalgia; gamma-Aminobutyric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Indapamide; Internal Medicine; Low Back Pain; Meta-Analysis as Topic; Perindopril; Pregabalin; Randomized Controlled Trials as Topic; Spinal Stenosis; Syphilis | 2009 |
[The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Perindopril | 2009 |
Implications of the ADVANCE study for clinical practice.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic | 2009 |
Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Female; Humans; Hypertension; Male; Perindopril; Propranolol; Risk Factors | 2009 |
Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Cytoprotection; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Perindopril; Randomized Controlled Trials as Topic; Titrimetry; Treatment Outcome | 2009 |
Treatment of hypertension in peripheral arterial disease.
Topics: Antihypertensive Agents; Humans; Hypertension; Intermittent Claudication; Perindopril; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Verapamil | 2009 |
Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Poland; Time Factors; Treatment Outcome | 2010 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Renin-Angiotensin System; Treatment Outcome | 2010 |
[Diagnosis and choice of therapy of arterial hypertension].
Topics: Antihypertensive Agents; Atenolol; Dementia, Vascular; Diagnosis, Differential; Female; Hemodynamics; Humans; Hypertension; Magnetic Resonance Imaging; Male; Perindopril | 2010 |
Perindopril for the treatment of hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2011 |
Combination perindopril/indapamide for the treatment of hypertension: a review.
Topics: Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Risk Factors | 2011 |
PROGRESS: Prevention of Recurrent Stroke.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome | 2011 |
What matters in ADVANCE and ADVANCE-ON.
Topics: Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Incidence; Indapamide; Kidney Failure, Chronic; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Which patients benefit the most from the perindopril/amlodipine combination.
Topics: Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Coronary Artery Disease; Humans; Hypertension; Perindopril | 2011 |
[New guidelines for hypertension in Russia--a priority of combined treatment].
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Humans; Hypertension; Indapamide; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Treatment Outcome | 2012 |
[Remodeling of vascular bed in patients with arterial hypertension: possibilities of diagnostics and correction].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Blood Vessels; Calcium Channel Blockers; Drug Combinations; Drug Synergism; Humans; Hypertension; Male; Microcirculation; Perindopril; Secondary Prevention; Treatment Outcome | 2012 |
The Hypertension in the Very Elderly Trial - latest data.
Topics: Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Delayed-Action Preparations; Dementia; Double-Blind Method; Drug Therapy, Combination; Fractures, Bone; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2013 |
[Therapy with perindopril: organoprotection, not just the antihypertensive effect].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Perindopril | 2012 |
[Control of arterial hypertension in stroke prevention].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brain Ischemia; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic | 2002 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Secondary prevention of stroke: old and new evidence.
Topics: Aged; Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Perindopril; Stroke | 2002 |
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
Topics: Acrylates; Adrenergic alpha-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Doxazosin; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Perindopril; Risk Factors; Sex Factors; Sodium Chloride Symporter Inhibitors; Thiophenes | 2002 |
The role of blood pressure lowering before and after stroke.
Topics: Aged; Antihypertensive Agents; Cerebral Infarction; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
[Arterial stiffness, wave reflections and myocardial protection: the REASON project].
Topics: Antihypertensive Agents; Arteries; Atenolol; Blood Pressure; Diastole; Drug Combinations; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Systole | 2003 |
[Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hypertension; Indapamide; Microcirculation; Perindopril | 2003 |
Trials on blood pressure-lowering and secondary stroke prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Perindopril; Secondary Prevention; Stroke | 2003 |
Very-low-dose combination: a first-line choice for the treatment of hypertension?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2003 |
Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Multiple Organ Failure; Perindopril; Treatment Outcome | 2003 |
Treatment of hypertension in peripheral arterial disease.
Topics: Antihypertensive Agents; Humans; Hypertension; Intermittent Claudication; Perindopril; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Verapamil | 2003 |
Treatment of hypertension and prevention of ischemic stroke.
Topics: Algorithms; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diltiazem; Humans; Hypertension; Losartan; Perindopril; Stroke | 2004 |
A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
[NO and hypertension].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Arteriosclerosis; Biopterins; C-Reactive Protein; Endothelium, Vascular; Humans; Hypertension; Mutation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Perindopril; Reactive Oxygen Species; Vasodilation | 2004 |
[Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Meta-Analysis as Topic; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2004 |
Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Hypolipidemic Agents; Male; Middle Aged; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2004 |
Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypertension; Perindopril | 2005 |
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
Perindopril: the reasonable choice in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Coronary Disease; Humans; Hypertension; Perindopril; Vascular Resistance | 2005 |
[Management of hypertension in elderly patients with stroke].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2005 |
Specific properties and effect of perindopril in controlling the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Perindopril; Renin-Angiotensin System | 2005 |
Evidence for benefits of perindopril in hypertension and its complications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Hypertension; Kidney Failure, Chronic; Perindopril | 2005 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Prospective Studies; Ramipril; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Time Factors | 2005 |
Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Rats | 2006 |
Pulse pressure reduction and cardiovascular protection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2006 |
Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Topics: Albuminuria; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2006 |
Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Vascular Diseases | 2006 |
Is hypertension a tissue perfusion disorder? Implications for renal and myocardial perfusion.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Capillaries; Clinical Trials as Topic; Coronary Circulation; Humans; Hypertension; Kidney; Microcirculation; Perindopril | 2006 |
Hypertension: which aspects of hypertension should we impact on and how?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2006 |
[PROGRESS].
Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Double-Blind Method; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk; Secondary Prevention; Stroke | 2006 |
[Overview of cardiovascular risk factors].
Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Male; Meta-Analysis as Topic; Perindopril; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Smoking Prevention; Spain; Vasodilator Agents | 2006 |
Perindopril versus angiotensin II receptor blockade in hypertension and coronary artery disease: implications of clinical trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
A review of Perindopril in the reduction of cardiovascular events.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Treatment Outcome | 2006 |
New insights from ADVANCE.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Internationality; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2007 |
The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2007 |
Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Models, Biological; Perindopril | 2007 |
ACE inhibition in hypertension: focus on perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Humans; Hypertension; Perindopril | 2007 |
[The prevention of the hypertension related damage in type-2 diabetes: the first step of the ADVANCE trial].
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Compliance; Humans; Hypertension; Indoles; Perindopril; Vasodilation | 1995 |
[The use of perindopril (prestarium) in arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Indoles; Perindopril | 1995 |
The blood vessel as a target organ in hypertension: protective effect of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Humans; Hypertension; Indoles; Muscle, Smooth, Vascular; Perindopril; Vascular Resistance | 1994 |
Clinical review of perindopril in the treatment of hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Indoles; Perindopril | 1994 |
[Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice].
Topics: Adult; Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus; Drug Evaluation; Drug Interactions; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Obesity; Perindopril; Psychotropic Drugs; Risk Factors | 1993 |
Coronary reserve in experimental myocardial hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiomegaly; Coronary Circulation; Humans; Hypertension; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Indoles; Myocardial Contraction; Perindopril; Rats | 1995 |
[Suppression of angiotensin-converting enzyme and myocardial ischemia].
Topics: Angina, Unstable; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Coronary Angiography; Double-Blind Method; Hemodynamics; Humans; Hypertension; Indoles; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Perindopril; Randomized Controlled Trials as Topic | 1999 |
Perindopril 2mg/indapamide 0.625mg. Fixed low-dose combination.
Topics: Animals; Antihypertensive Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 1999 |
Angiotensin converting enzyme inhibitors: are they preferred first-line therapy?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Comorbidity; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome | 2000 |
Perindopril: an updated review of its use in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolysis; Hemodynamics; Humans; Hypertension; Perindopril; Proteinuria | 2001 |
Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
Topics: Adult; Age Factors; Aged; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypokalemia; Indapamide; Kidney Diseases; Middle Aged; Perindopril; Randomized Controlled Trials as Topic | 2001 |
Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Perindopril | 2001 |
Efficacy of perindopril in the treatment of systemic hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Coronary Vessels; Dose-Response Relationship, Drug; Humans; Hypertension; Perindopril | 2001 |
Dosage considerations with perindopril for systemic hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hypertension; Perindopril | 2001 |
Effects of perindopril on cardiovascular remodeling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Hypertrophy, Left Ventricular; Perindopril; Vascular Resistance; Ventricular Remodeling | 2001 |
Safety profile of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Perindopril; Product Surveillance, Postmarketing | 2001 |
Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Treatment Outcome | 2001 |
ACE inhibitors in vascular disease: some PROGRESS, more HOPE.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Forecasting; Humans; Hypertension; Male; Middle Aged; Perindopril; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome; United Kingdom; Vascular Diseases | 2001 |
Blood pressure and stroke; the PROGRESS trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2001 |
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Atenolol; Biphenyl Compounds; Cilazapril; Humans; Hypertension; Irbesartan; Losartan; Perindopril; Tetrazoles | 2002 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
[Prevention of pathological aging. The arterial hypertension example].
Topics: Adult; Aged; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output; Cardiovascular Diseases; Cerebral Arterial Diseases; Dementia, Vascular; Glomerular Filtration Rate; Humans; Hypertension; Indoles; Middle Aged; Perindopril | 1992 |
Vascular effects of perindopril: from experimental to clinical investigation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Humans; Hypertension; Indoles; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred Strains; Vascular Resistance | 1991 |
Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomegaly; Elasticity; Humans; Hypertension; Indoles; Perindopril; Vascular Resistance | 1991 |
[Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Aorta; Blood Pressure; Cardiomegaly; Compliance; Echocardiography; Humans; Hypertension; Indoles; Perindopril; Single-Blind Method | 1991 |
Perindopril (Coversyl)--a new ACE inhibitor. Perindopril--a review of its pharmacokinetics and clinical pharmacology.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Indoles; Perindopril; Renal Circulation | 1991 |
The safety and acceptability of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Humans; Hypertension; Hypotension; Indoles; Kidney; Perindopril | 1990 |
Clinical pharmacology of perindopril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Hypertension; Indoles; Perindopril | 1990 |
Vascular effects of ACE inhibition by perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Hypertension; Indoles; Perindopril; Rats | 1990 |
Vascular haemodynamic effects of perindopril in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Hemodynamics; Humans; Hypertension; Indoles; Perindopril; Renin-Angiotensin System | 1990 |
Perindopril safety and tolerance in at-risk patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Complications; Diabetes Mellitus; Drug Tolerance; Humans; Hypertension; Indoles; Perindopril | 1990 |
Perindopril. A review of its pharmacokinetics and clinical pharmacology.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Humans; Hypertension; Indoles; Perindopril | 1990 |
First-line treatment in hypertension. Role of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Evaluation; Humans; Hypertension; Indoles; Perindopril | 1990 |
[Antihypertensive effect of perindopril. Experimental pharmacology].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renovascular; Indoles; Kidney; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 1989 |
[Tolerance and safety of the use of perindopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Humans; Hyperkalemia; Hypertension; Hypotension; Indoles; Kidney; Perindopril | 1989 |
Antihypertensive effect of perindopril: experimental pharmacology.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dogs; Hypertension; Indoles; Kidney; Perindopril; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance | 1989 |
Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitors; Diastole; Humans; Hypertension; Indoles; Perindopril; Systole; Vascular Resistance | 1989 |
309 trial(s) available for perindopril and Blood Pressure, High
| Article | Year |
|---|---|
A Differential Response to Antihypertensive Therapy in African Men and Women: Insights From the CREOLE Trial.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Perindopril; Treatment Outcome | 2022 |
Effect of 3, 2-Drug Combinations of Antihypertensive Therapies on Blood Pressure Variability in Black African Patients: Secondary Analyses of the CREOLE Trial.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Thiazides | 2022 |
The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension - a Postmarketing Study.
Topics: Antihypertensive Agents; Blood Pressure; Drug Combinations; Essential Hypertension; Humans; Hypertension; Indapamide; Perindopril; Prospective Studies; Treatment Outcome | 2022 |
A randomized trial of genotype-guided perindopril use.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cough; Genotype; Humans; Hypertension; Middle Aged; Perindopril; Young Adult | 2023 |
Evaluation of Clinical Acceptability of Perindopril / Indapamide Single-pill Combination in Moderate to Severe Hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; India; Middle Aged; Perindopril; Prospective Studies | 2019 |
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Topics: Adult; Aged; Body-Weight Trajectory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypertension; Indapamide; Life Style; Male; Middle Aged; Obesity; Overweight; Perindopril; Risk Factors; Weight Gain; Weight Loss | 2020 |
Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Outpatients; Perindopril; Systole; Time Factors | 2019 |
Blood-pressure Lowering Efficacy and Safety of Perindopril / Indapamide / Amlodipine Single-pill Combination in Hypertensive Patients: Phase III Trial in India.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; India; Perindopril; Quality of Life; Treatment Outcome | 2020 |
Effect of Perindopril/Indapamide on Cerebral Blood Flow in Middle-Aged, Treatment-Naïve Patients with Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cerebrovascular Circulation; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Indapamide; Magnetic Resonance Imaging; Male; Middle Aged; Perindopril | 2020 |
Rationale and design of the comparison of 3 combination therapies in lowering blood pressure in black Africans (CREOLE study): 2 × 3 factorial randomized single-blind multicenter trial.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Research Design; Single-Blind Method | 2018 |
Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Atorvastatin; Blood Pressure; Canada; Cohort Studies; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2018 |
Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.
Topics: Adult; Africa South of the Sahara; Aged; Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Middle Aged; Perindopril; Single-Blind Method | 2019 |
Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Severity of Illness Index | 2019 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Intention to Treat Analysis; Male; Microvessels; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Treatment Outcome | 2019 |
Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Monitoring; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2019 |
[Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril].
Topics: Benzazepines; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Cerebrovascular Circulation; Coronary Disease; Drug Combinations; Electrocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Perindopril; Research Design; Treatment Outcome; Ultrasonography, Doppler | 2012 |
Increased pulse pressure linked to dementia: further results from the Hypertension in the Very Elderly Trial - HYVET.
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Proportional Hazards Models; Pulsatile Flow; Regression Analysis; Risk Factors; Treatment Outcome | 2013 |
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan | 2013 |
[Effect of a fixed-dose perindopril and amlodipine combination on intrarenal hemodynamic and kidney functional parameters in patients with essential hypertension].
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Nephritis; Perindopril | 2013 |
[Effect of perindopril on the processes of subclinical inflammation in patients with arterial hypertension and type 2 diabetes mellitus].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arterial Pressure; C-Reactive Protein; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Inflammation; Male; Middle Aged; Perindopril; Treatment Outcome; Vasodilation | 2013 |
[Combined therapy of arterial hypertension with the fixed combination of perindopril arginine / amlodipine in real clinical practice: the organization and the main results of the program CONSTANTA].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Program Development; Treatment Outcome | 2013 |
The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension.
Topics: Adult; Aged; Amlodipine; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Middle Aged; Multivariate Analysis; Perindopril; Risk Assessment; Tetrazoles; Treatment Outcome | 2013 |
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models | 2014 |
Efficacy of single-pill perindopril/indapamide in patients with hypertension and type 2 diabetes.
Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Incidence; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2014 |
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Myocardial Infarction; Perindopril; Retrospective Studies; Risk Reduction Behavior; Stroke | 2014 |
Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterial Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Female; France; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Selection; Perindopril; Sex Factors; Time Factors; Treatment Outcome | 2015 |
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Recurrence; Risk Factors; Stroke | 2014 |
[Comparison pharmacoeconomics organoprotection using fixed combinations of antihypertensive drugs].
Topics: Antihypertensive Agents; Drug Therapy, Combination; Economics, Pharmaceutical; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2014 |
Subgroup and per-protocol analyses from the Hypertension in the Very Elderly Trial.
Topics: Age Factors; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Risk Assessment; Stroke | 2014 |
Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Combinations; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydrochlorothiazide; Hypertension; Iodine Radioisotopes; Iodohippuric Acid; Norethindrone; Perindopril; Poland; Polypharmacy; Postmenopause; Progestins; Pulse Wave Analysis; Renal Plasma Flow; Time Factors; Transdermal Patch; Treatment Outcome; Vascular Stiffness | 2015 |
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Risk Factors | 2014 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Adult; Aged; Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Valsartan | 2015 |
Efficacy and safety evaluation of perindopril-lercanidipine combined therapy in patients with mild essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Dihydropyridines; Drug Therapy, Combination; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of perindopril arginine + amlodipine in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Potassium; Prospective Studies | 2015 |
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placeb
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Female; Frail Elderly; Humans; Hypertension; Incidence; Indapamide; Male; Perindopril; Quality of Life; Stroke | 2015 |
[Direct comparison of endothelial and metabolic effects of perindopril combination with indapamide retard or hydrochlorothiazide].
Topics: Aged; Antihypertensive Agents; Biological Availability; Blood Pressure; Carbohydrate Metabolism; Delayed-Action Preparations; Drug Combinations; Drug Monitoring; Endothelium, Vascular; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Lipid Metabolism; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Treatment Outcome; Waist Circumference | 2014 |
Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Administration Schedule; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril | 2015 |
The effects of angiotensin II signaling blockade on platelet activity in subjects with hypertension.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Hypertension; Life Style; Male; Middle Aged; Perindopril; Platelet Function Tests; Treatment Outcome; Valsartan | 2015 |
Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Hypolipidemic Agents; Male; Nifedipine; Non-alcoholic Fatty Liver Disease; Obesity; Perindopril; Simvastatin | 2015 |
Antihypertensive therapy increases natural immunity response in hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hydrochlorothiazide; Hypertension; Immunity, Innate; Indapamide; Male; Middle Aged; Perindopril; Single-Blind Method | 2015 |
[Efficacy comparison between 5 mg perindopril arginine salt and 4 mg perindopril tert-butylamine salt for patients with mild to moderate essential hypertension].
Topics: Antihypertensive Agents; Arginine; Blood Pressure; Butylamines; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Perindopril; Sodium Chloride | 2015 |
Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2016 |
The advantages of combination therapy on hypertension: development of immediate release perindopril-indapamide tablet and assessment of bioequivalence studies.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Tablets; Therapeutic Equivalency; Young Adult | 2016 |
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome | 2016 |
[New drug combination for initial therapy].
Topics: Amlodipine; Dose-Response Relationship, Drug; Drug Combinations; Europe; Humans; Hypertension; Perindopril | 2016 |
Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Tetrazoles | 2016 |
Short-Term Cardioprotective Effects of the Original Perindopril/Amlodipine Fixed-Dose Combination in Patients with Stable Coronary Artery Disease: Results of the PAPA-CAD Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiotonic Agents; Coronary Artery Disease; Drug Combinations; Drug Monitoring; Exercise Tolerance; Female; Heart Rate; Humans; Hungary; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors; Treatment Outcome | 2016 |
Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Continuous Positive Airway Pressure; Cross-Over Studies; Double-Blind Method; Drug Chronotherapy; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Sleep Apnea, Obstructive | 2017 |
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril | 2017 |
Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril; Prospective Studies; Time Factors; Treatment Outcome | 2008 |
Lowering of brachial pulse pressure in 9379 hypertensives with type 2 diabetes and reduction of cardiovascular events.
Topics: Antihypertensive Agents; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Indapamide; Male; Middle Aged; Multivariate Analysis; Perindopril; Prospective Studies; Risk Factors; Treatment Outcome | 2008 |
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cognition; Dementia; Double-Blind Method; Female; Geriatric Assessment; Humans; Hypertension; Incidence; Indapamide; Longitudinal Studies; Male; Mental Status Schedule; Neuropsychological Tests; Perindopril | 2008 |
Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asian People; Blood Pressure; Canada; Cardiovascular Diseases; Diabetes Mellitus; Family Practice; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril; Severity of Illness Index; Time Factors; Treatment Outcome | 2008 |
Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Combined Modality Therapy; Emergencies; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hypertension; Labetalol; Male; Middle Aged; Perindopril; Rest; Retrospective Studies; Treatment Outcome | 2008 |
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Peripheral Vascular Diseases; Scandinavian and Nordic Countries; Stroke; Thiazides; United Kingdom | 2008 |
Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome; Vasodilation | 2008 |
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Topics: Aged; Antihypertensive Agents; Aortic Diseases; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Predictive Value of Tests; Pulse; Treatment Outcome | 2009 |
Lowering blood pressure reduces renal events in type 2 diabetes.
Topics: Age of Onset; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Indapamide; Male; Perindopril; Systole | 2009 |
Coronary heart disease benefits from blood pressure and lipid-lowering.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Blood Pressure; Coronary Disease; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Risk Factors; Risk Reduction Behavior; Sodium Chloride Symporter Inhibitors | 2009 |
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients.
Topics: Adult; Antihypertensive Agents; Atenolol; Brachial Artery; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Nitroglycerin; Perindopril; Vasodilation | 2009 |
Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
Topics: Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Longitudinal Studies; Male; Mental Status Schedule; Perindopril; Psychometrics; Risk Factors | 2009 |
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Blood Glucose; Confidence Intervals; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2009 |
Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diastole; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Long-Term Care; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Treatment Failure | 2009 |
[Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2009 |
Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Clinical Medicine; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril | 2009 |
Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.
Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Arteries; Atenolol; Bendroflumethiazide; Blood Pressure Determination; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Elasticity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Perindopril; Probability; Regression Analysis; Risk Assessment; Systole; Treatment Outcome | 2009 |
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Aged; Amlodipine; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Thiazides | 2009 |
The effects of perindopril on aortic elasticity and inflammatory markers in hypertensive patients.
Topics: Antihypertensive Agents; Aorta; Biomarkers; Elasticity; Female; Humans; Hypertension; Inflammation; Male; Middle Aged; Perindopril | 2009 |
Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan | 2009 |
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Placebos | 2009 |
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome | 2009 |
Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
Topics: Adiponectin; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cilazapril; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Insulin; Lipids; Male; Middle Aged; Perindopril; Pilot Projects; Time Factors; Treatment Outcome | 2009 |
[Structural-functional properties of the vascular wall in hypertensive patients with coronary heart disease: effects of felodipin and perindopril].
Topics: Antihypertensive Agents; Arteries; Endothelium, Vascular; Felodipine; Humans; Hypertension; Middle Aged; Myocardial Ischemia; Perindopril | 2009 |
The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines.
Topics: Adult; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Case-Control Studies; Chemokine CCL2; Drug Therapy, Combination; Female; Humans; Hypertension; Interleukins; Male; Middle Aged; Monocytes; Perindopril; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2009 |
[Echocardiography of left ventricular mass in patients with essential hypertension].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Reproducibility of Results; Risk Factors; Ultrasonography | 2009 |
Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Primary Health Care; Prospective Studies; Risk Factors; Romania; Severity of Illness Index | 2009 |
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cerebral Amyloid Angiopathy; Cerebral Arteries; Cerebral Hemorrhage; Comorbidity; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Placebos; Risk Factors; Risk Reduction Behavior; Treatment Outcome | 2010 |
[Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan; Vascular Resistance | 2009 |
The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Models, Biological; Patient Selection; Perindopril; Risk; Risk Assessment; Risk Factors | 2010 |
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Placebos | 2010 |
Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Dementia; Depression; Female; Geriatric Assessment; Humans; Hypertension; Indapamide; Longitudinal Studies; Male; Perindopril; Risk Factors; Stroke | 2010 |
Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Capillaries; Cross-Over Studies; Cross-Sectional Studies; Diuretics; Drug Combinations; Endothelium, Vascular; Female; Fingers; France; General Practice; Humans; Hypertension; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Vasodilation | 2010 |
Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril | 2010 |
The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Aging; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Fractures, Bone; Humans; Hypertension; Incidence; Indapamide; Male; Perindopril; Placebos; Risk Factors | 2010 |
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Cardiac Catheterization; Coronary Sinus; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Lipids; Lisinopril; Male; Middle Aged; Perindopril; Prospective Studies; Pulmonary Wedge Pressure; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Young Adult | 2010 |
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
Topics: Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Models, Theoretical; Perindopril | 2010 |
Monitoring adherence to medication by measuring change in blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Patient Compliance; Perindopril; Stroke; Treatment Outcome | 2010 |
Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
Topics: Antihypertensive Agents; Australia; Blood Pressure; Cost-Benefit Analysis; Diabetic Angiopathies; Hospital Costs; Humans; Hypertension; Indapamide; Life Expectancy; Perindopril; Quality of Life | 2010 |
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Rats; Rats, Inbred SHR | 2011 |
Bedtime versus at awakening administration of BP lowering drugs--is it the way to success?
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Cohort Studies; Drug Chronotherapy; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome; Verapamil | 2009 |
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Double-Blind Method; Drug Therapy, Combination; Elasticity; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2011 |
Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Indapamide; Male; Perindopril; Stroke | 2012 |
Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.
Topics: Adult; Aged; Allopurinol; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Blood Pressure; Compliance; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Perindopril; Uric Acid; Uricosuric Agents | 2011 |
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Treatment Outcome | 2011 |
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom | 2011 |
Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; China; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hypertension; Indapamide; Male; Odds Ratio; Perindopril; Severity of Illness Index; Tunisia | 2011 |
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Odds Ratio; Perindopril; Risk Factors; Treatment Outcome | 2012 |
[Uncontrolled arterial hypertension--new possibilities in solving problems of increasing the effectiveness of treatment].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2012 |
Optimization of blood pressure treatment with fixed-combination perindopril/amlodipine in patients with arterial hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Perindopril; Prospective Studies | 2012 |
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Topics: Age Factors; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Male; Perindopril; Proportional Hazards Models; Proteinuria; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2013 |
Effect of perindopril on pulse-wave velocity and endothelin-1 in black hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Blood Pressure; Dose-Response Relationship, Drug; Endothelin-1; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Pulsatile Flow; Treatment Outcome; Ultrasonography, Doppler, Color; Vascular Stiffness | 2012 |
Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Indapamide; Lipids; Male; Middle Aged; Perindopril; Time Factors; Uric Acid | 2013 |
Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Databases, Factual; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Sex Characteristics | 2002 |
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Perindopril; Research Design; Treatment Outcome | 2002 |
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].
Topics: Atenolol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Indapamide; Patient Selection; Perindopril; Systole; Time Factors | 2002 |
Different drug classes have variable effects on blood pressure depending on the time of day.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Felodipine; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Perindopril | 2003 |
Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Determination; Diastole; Feasibility Studies; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Prospective Studies; Random Allocation; Severity of Illness Index; Single-Blind Method; Statistics as Topic; Systole; Telmisartan; Treatment Outcome | 2002 |
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Death, Sudden, Cardiac; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2003 |
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Coronary Circulation; Dose-Response Relationship, Drug; Female; Fibrinolysis; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Receptor, Angiotensin, Type 1; Tissue Plasminogen Activator | 2003 |
[Arterial stiffness, wave reflections and myocardial protection: the REASON project].
Topics: Antihypertensive Agents; Arteries; Atenolol; Blood Pressure; Diastole; Drug Combinations; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Systole | 2003 |
[ADVANCE study: objectives, design and current status].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Vascular Diseases | 2003 |
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dementia; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Treatment Outcome | 2003 |
Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Pilot Projects; Radiography; Tomography, Emission-Computed; Vasodilation | 2003 |
Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Half-Life; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Perindopril; Quinapril; Renal Dialysis; Renal Insufficiency; Tetrahydroisoquinolines | 2003 |
A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Perindopril; Tetrazoles | 2003 |
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Humans; Hypertension; Incidence; Perindopril; Risk Reduction Behavior; Secondary Prevention; Stroke | 2003 |
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk; Secondary Prevention; Stroke; Treatment Outcome | 2004 |
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2004 |
Antihypertensive utility of perindopril in a large, general practice-based clinical trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Safety; Treatment Outcome; United States | 2004 |
Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Black People; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome; United States; White People | 2004 |
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diastole; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Rate; Humans; Hypertension; Incidence; Indapamide; Male; Middle Aged; Perindopril; Systole; Treatment Outcome | 2004 |
[Severe heart failure: treatment optimisation and monitoring using plasma NT-proBNP levels--an useful tool in clinical practice].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Heart Failure; Humans; Hypertension; Indapamide; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Propanolamines; Reference Values | 2004 |
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Topics: Age Distribution; Aged; Angiotensin-Converting Enzyme Inhibitors; Asia; Australia; Blood Pressure; Coronary Disease; Europe; Female; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Proportional Hazards Models; Risk Factors; Sex Distribution; Stroke | 2004 |
Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Comorbidity; Diabetes Complications; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Proportional Hazards Models; Recurrence; Risk; Risk Factors; Stroke; Treatment Outcome | 2004 |
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diastole; Diuretics; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; South Africa; Systole; Time Factors; Treatment Outcome | 2004 |
Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Collagen; Elasticity; Female; Humans; Hypertension; Male; Matrix Metalloproteinase 1; Middle Aged; Perindopril; Pulsatile Flow; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome; Vascular Resistance | 2004 |
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome; Ultrasonography | 2004 |
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril | 2004 |
Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Female; Heart; Humans; Hypertension; Male; Middle Aged; Perindopril; Positron-Emission Tomography; Vascular Resistance; Vasodilator Agents | 2004 |
[Evaluation of the antihypertensive efficacy and tolerability of fixed very low-dose perindopril/indapamid combination in patients with mild to moderate hypertension. Results of a Czech and Slovak multicentric study].
Topics: Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Echocardiography; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Ventricular Function, Left | 2004 |
[Daily blood pressure profiles and endothelial functions during long-term treatment of arterial hypertension with angiotensin-converting enzyme inhibitors].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Circadian Rhythm; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Severity of Illness Index; Time Factors | 2004 |
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Community Health Services; Female; Health Services for the Aged; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome; United States | 2004 |
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies | 2004 |
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2004 |
The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Single-Blind Method; Telmisartan | 2004 |
Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Ankle; Aorta; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Prospective Studies; Pulse; Tetrazoles; Valine; Valsartan | 2005 |
[Comparison of noliprel and caposide efficacy in patients with arterial hypertension of high risk].
Topics: Antihypertensive Agents; Captopril; Cardiomegaly; Female; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2005 |
A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Follow-Up Studies; Humans; Hypertension; Malaysia; Male; Middle Aged; Perindopril; Prevalence; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Placebos; Risk; Stroke; Time Factors; Treatment Outcome | 2005 |
Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Renin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2005 |
Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Potassium; Regression Analysis; Treatment Outcome | 2005 |
Effect of the angiotensin-converting enzyme inhibitor perindopril on 24-hour blood pressure in patients with lacunar infarction: comparison between dippers and non-dippers.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain Infarction; Circadian Rhythm; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Physicians' Offices | 2005 |
[Comparative efficacy of fixed dose combinations of perindopril with indapamide and captopril with hydrochlorothiazide in patients with high risk hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk Factors | 2005 |
Rationale and methodology of monitoring ambulatory blood pressure and arterial compliance in the Hypertension in the Very Elderly Trial.
Topics: Aged, 80 and over; Arteries; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Clinical Protocols; Double-Blind Method; Humans; Hypertension; Indapamide; Office Visits; Perindopril | 2006 |
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Topics: Age Distribution; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diastole; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Treatment Outcome; Ventricular Remodeling | 2006 |
Use of antihypertension agents for the suppression of arterial pulse pressure waveforms in patients with intracranial aneurysms.
Topics: Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Brain; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Intracranial Aneurysm; Irbesartan; Isosorbide Dinitrate; Male; Middle Aged; Perindopril; Risk Factors; Tetrazoles; Treatment Outcome | 2006 |
Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brachial Artery; Carotid Arteries; Diabetes Complications; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Single-Blind Method; Tunica Intima; Tunica Media | 2006 |
[Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Severity of Illness Index; Time Factors | 2006 |
[Comparison of the effectiveness of moxonidine and prestarium in postmenopausal women with mild and moderate arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Echocardiography; Electrocardiography; Female; Heart Ventricles; Humans; Hypertension; Imidazoles; Middle Aged; Perindopril; Postmenopause; Severity of Illness Index; Treatment Outcome; Ventricular Function | 2006 |
[The use of moxonidine in women with arterial hypertension in postmenopausal period].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Dydrogesterone; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hypertension; Imidazoles; Lipids; Perindopril; Postmenopause; Treatment Outcome | 2006 |
Effects of perindopril and hydrochlorothiazide on selected indices of oxidative stress in the blood of elderly patients with essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Catalase; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Malondialdehyde; Nitrates; Nitrites; Oxidative Stress; Perindopril; Superoxide Dismutase; Superoxide Dismutase-1 | 2006 |
ADVANCE: breaking new ground in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril | 2006 |
Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies | 2006 |
The impact of one or two missed doses on the duration of action of combined perindopril and indapamide.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Time Factors | 2007 |
[The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril].
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Hemostasis; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Renin-Angiotensin System; Treatment Outcome | 2006 |
Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Double-Blind Method; Female; Humans; Hypertension; Losartan; Malaysia; Male; Perindopril; Polymorphism, Genetic; Pulse; Receptor, Angiotensin, Type 1 | 2007 |
Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Practice Guidelines as Topic; Time Factors | 2006 |
ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Dropouts; Perindopril; Risk; Systole; Treatment Outcome | 2006 |
Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cilazapril; Cough; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazolidines; Incidence; Male; Middle Aged; Perindopril; Philippines; Treatment Outcome | 2007 |
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor | 2007 |
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Case-Control Studies; Cerebral Hemorrhage; Cerebrovascular Disorders; Female; Humans; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Odds Ratio; Particle Size; Perindopril; Prognosis; Risk Assessment; Risk Factors; Secondary Prevention; Systole | 2007 |
Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2007 |
Vascular outcome in type 2 diabetes: an ADVANCE?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Treatment Outcome | 2007 |
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2007 |
[Advanced credit: patient enrolling and therapy initiation in the ADVANCE trial].
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Patient Selection; Perindopril; Research Design; Treatment Outcome | 2007 |
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Time Factors; Treatment Outcome | 2007 |
[The therapy of complicated forms of essential hypertension with the ACE inhibitor perindopril].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Brain Ischemia; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2007 |
[The activity of nonspecific inflammation in hypertensive patients].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; C-Reactive Protein; Circadian Rhythm; Diuretics; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Indapamide; Inflammation; Interleukin-6; Male; Middle Aged; Nephelometry and Turbidimetry; Perindopril; Treatment Outcome | 2007 |
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; England; Female; Humans; Hypertension; Male; Middle Aged; Patient Selection; Perindopril; Sweden | 2008 |
[ADVANCE: a morbidity mortality study of diabetes and hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Humans; Hypertension; Indapamide; Middle Aged; Perindopril | 2008 |
[PRIVILEGIYA (Privilege) study - Prestarium in the treatment of arterial hypertension: antihypertensive effectiveness and safety in comparison with enalapril].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Administration Schedule; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Russia; Treatment Outcome | 2007 |
[Effect of a fixed combination of perindopril and indapamide on 24-hour blood pressure profile, morpho-functional parameters of the heart, heart rate variability, functional state of the kidney, and quality of life in patients with arterial hypertension c
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Kidney; Male; Metabolic Syndrome; Middle Aged; Perindopril; Quality of Life; Treatment Outcome | 2007 |
Treatment of hypertension in patients 80 years of age or older.
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2008 |
Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Circulation; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Nitroglycerin; Perindopril; Radial Artery | 2008 |
An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cost-Benefit Analysis; Female; Hospital Costs; Humans; Hypertension; Male; Markov Chains; Middle Aged; Monte Carlo Method; Perindopril; Quality-Adjusted Life Years; Stroke | 2009 |
Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
Topics: Adult; Aged; Cilazapril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2008 |
The comparative effects of metoprolol and perindopril on aortic elasticity in young patients with prehypertension.
Topics: Adult; Antihypertensive Agents; Aorta; Elasticity; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Perindopril; Prospective Studies; Single-Blind Method | 2008 |
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carotid Arteries; Diuretics; Double-Blind Method; Europe; Femoral Artery; Humans; Hydrochlorothiazide; Hypertension; Indoles; Middle Aged; Perindopril; Prospective Studies; Sodium Chloride Symporter Inhibitors; Tunica Intima | 1995 |
Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Indoles; Isradipine; Male; Middle Aged; Perindopril; Vascular Resistance | 1995 |
Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Cholesterol; Enalapril; Female; Glucose Tolerance Test; Humans; Hypertension; Indoles; Insulin; Lipids; Lipoproteins, HDL; Lisinopril; Male; Middle Aged; Perindopril; Triglycerides | 1994 |
Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Lipids; Male; Middle Aged; Perindopril; Triglycerides | 1994 |
[24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Indoles; Middle Aged; Perindopril | 1995 |
Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Cyclosporine; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Indoles; Kidney; Kidney Transplantation; Male; Middle Aged; Perindopril; Transplantation, Homologous | 1995 |
Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Atenolol; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1995 |
[Course of the left ventricular mass in a population of 893 hypertensive patients. Effects of treatment with perindopril].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Myocardial Contraction; Perindopril; Time Factors; Ventricular Function, Left | 1994 |
Efficacy and acceptability of perindopril in essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1994 |
[Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Double-Blind Method; Heart; Humans; Hypertension; Indoles; Middle Aged; Perindopril; Ultrasonography, Doppler | 1994 |
Treatment of essential hypertension in general practice: an open-label study of 47,351 French hypertensive patients treated for one year with perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Product Surveillance, Postmarketing | 1994 |
Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen.
Topics: Antihypertensive Agents; Arteries; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indoles; Isradipine; Male; Perindopril; Vascular Resistance | 1994 |
Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
Topics: Adolescent; Adult; Antihypertensive Agents; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1994 |
Effectiveness of blood pressure control with once daily administration of enalapril and perindopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Enalapril; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1994 |
ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Treatment Outcome | 1994 |
Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial (PROTECT).
Topics: Adult; Antihypertensive Agents; Arteries; Clinical Protocols; Double-Blind Method; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril; Ultrasonography | 1993 |
Effect of perindopril and amiloride/hydrochlorothiazide on haemodynamics and vessel wall properties of large arteries.
Topics: Adult; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Arteries; Double-Blind Method; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril; Vascular Resistance; Vasodilation | 1993 |
Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril; Severity of Illness Index; Time Factors | 1994 |
Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Indoles; Male; Patient Satisfaction; Perindopril; Treatment Outcome | 1993 |
A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome | 1993 |
Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1993 |
[Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice].
Topics: Adult; Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diabetes Mellitus; Drug Evaluation; Drug Interactions; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Obesity; Perindopril; Psychotropic Drugs; Risk Factors | 1993 |
Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Synergism; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1995 |
The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients.
Topics: Adult; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Arteries; Blood Pressure; Compliance; Diuretics; Double-Blind Method; Drug Combinations; Female; Heart; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril; Sodium Chloride Symporter Inhibitors | 1995 |
Effect of dose on trough peak ratio of antihypertensive drugs in elderly hypertensive males.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Enalapril; Felodipine; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1995 |
Effect of perindopril and metoprolol on left ventricular hypertrophy and performance in essential hypertension.
Topics: Adult; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Indoles; Male; Metoprolol; Middle Aged; Perindopril | 1995 |
Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Indoles; Isradipine; Male; Middle Aged; Perindopril | 1995 |
Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dinoprostone; Humans; Hypertension; Indoles; Kallikreins; Male; Middle Aged; Perindopril; Renin | 1996 |
Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Immunosuppressive Agents; Indoles; Kidney Transplantation; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies; Renal Circulation; Vascular Resistance | 1996 |
Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Double-Blind Method; Exercise Test; Female; Humans; Hypertension; Indoles; Insulin; Lipids; Male; Middle Aged; Obesity; Perindopril | 1996 |
An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Potassium; Retrospective Studies; Therapeutic Equivalency | 1995 |
Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Calcium Channel Blockers; Cohort Studies; Female; Genotype; Hemodynamics; Humans; Hypertension; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin | 1996 |
Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1997 |
Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Placebos; Ultrasonography | 1997 |
A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group.
Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1996 |
[Perindopril in monotherapy of primary hypertension--6 month observation].
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Echocardiography; Female; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1997 |
Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Hormones; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Water-Electrolyte Balance | 1998 |
Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
Topics: Adrenergic beta-Antagonists; Aged; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Nifedipine; Perindopril; Sodium Chloride Symporter Inhibitors | 1997 |
Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Substance Withdrawal Syndrome | 1998 |
Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Carotid Artery, Common; Diuretics; Double-Blind Method; Drug Therapy, Combination; Elasticity; Hemodynamics; Humans; Hypertension; Hypertrophy; Indoles; Middle Aged; Perindopril; Radial Artery; Tunica Intima | 1998 |
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Leg; Male; Middle Aged; Perindopril; Platelet Aggregation; Propanolamines; Reference Values; Regional Blood Flow; Rheology; Vascular Resistance | 1998 |
Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Renal Insufficiency | 1998 |
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Indoles; Insulin Resistance; Losartan; Male; Middle Aged; Obesity; Perindopril | 1998 |
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Indoles; Male; Middle Aged; Perindopril; Prognosis; Recurrence; Survival Rate; Treatment Outcome; World Health Organization | 1998 |
Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Diabetic Angiopathies; Double-Blind Method; Female; Fluorescein Angiography; Hemodynamics; Humans; Hypertension; Indoles; Middle Aged; Perindopril; Regional Blood Flow; Retinal Vessels | 1998 |
Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.
Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Prognosis; Safety | 1999 |
Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Drug Resistance; Heart Rate; Humans; Hypertension; Indapamide; Indoles; Middle Aged; Perindopril | 1998 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Potassium; Safety; Treatment Outcome | 1999 |
Comparative efficacy of perindopril and enalapril once daily using 24-hour ambulatory blood pressure monitoring.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 1999 |
Effectiveness and metabolic effects of perindopril and diuretics combination in primary hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Renin; Sodium Chloride Symporter Inhibitors | 1999 |
Persistence of anti-hypertensive effect after missed dose of perindopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Male; Middle Aged; Perindopril; Time Factors | 1999 |
Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Hypertension; Lipoproteins; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1; Thrombomodulin; Tissue Plasminogen Activator | 1999 |
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Risk Factors; Secondary Prevention; Stroke | 1999 |
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome | 2000 |
Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Safety; Treatment Outcome | 2000 |
Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery.
Topics: Aged; Aging; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cognition; Cross-Over Studies; Diagnosis, Computer-Assisted; Diuretics; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Neuropsychological Tests; Perindopril; Triamterene | 1999 |
Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril | 2000 |
Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Indapamide; Longitudinal Studies; Male; Perindopril; Treatment Outcome | 2000 |
Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Perindopril; Posture; Supine Position | 2000 |
Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Perindopril; Postmenopause; Prevalence; Prospective Studies; Urinary Incontinence, Stress | 2000 |
[The effect of amlodipine, nifedipine and perindopril on insulin sensitivity and blood lipid of patients with essential hypertension].
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Nifedipine; Perindopril | 1998 |
Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arterioles; Blood Pressure; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardium; Perindopril; Prospective Studies; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2000 |
Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.
Topics: Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Glucose; Heart Ventricles; Humans; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Myocardium; Obesity; Perindopril; Ventricular Function, Left | 2000 |
Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Brain; Carotid Artery Diseases; Cerebrovascular Circulation; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Circulation; Severity of Illness Index; Stroke; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Vascular Resistance | 2001 |
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Clinical Protocols; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Placebos; Prospective Studies; Quality Control; Randomized Controlled Trials as Topic | 2001 |
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Losartan; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2001 |
Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitors; Brachial Artery; Catheters, Indwelling; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril | 2001 |
Comparison of the effect of perindopril and acebutolol on cerebral hemodynamics in hypertensive patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Circulation; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Ultrasonography, Doppler, Transcranial | 2001 |
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor | 2001 |
[Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril | 2001 |
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Stroke | 2001 |
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 2001 |
[The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2001 |
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aorta; Arteries; Asthenia; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Cough; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Follow-Up Studies; Headache; Heart Rate; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Pulse; Treatment Outcome | 2001 |
[Effects of perindopril and its combination with indapamide on risk stratification in patients with hypertension].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk | 2001 |
Does ACE inhibition slow progression of glomerulopathy in patients with Type 2 diabetes mellitus?
Topics: Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension; Kidney Glomerulus; Microscopy, Electron; Middle Aged; Perindopril; Placebos; Proteinuria | 2001 |
Assessment of perindopril's efficacy on arterial distensibility in mild to moderate hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arteries; Blood Flow Velocity; Chi-Square Distribution; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2001 |
Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Secondary Prevention; Stroke; Treatment Outcome | 2002 |
[Greater reduction of urinary albumin excretion in hypertensive patients with perindopril than nifedipine].
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Nifedipine; Perindopril | 1999 |
A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Nitrendipine; Perindopril; Proteinuria; Technetium Tc 99m Pentetate | 2001 |
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Topics: Antihypertensive Agents; Arteries; Brachial Artery; Carotid Arteries; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Vascular Resistance | 2001 |
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indapamide; Losartan; Perindopril; Safety; Time Factors | 2001 |
Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Brachial Artery; Carotid Arteries; Cross-Over Studies; Humans; Hypertension; Middle Aged; Perindopril | 2001 |
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertension; Losartan; Male; Middle Aged; Perindopril; Plasminogen Activator Inhibitor 1 | 2002 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor | 2002 |
Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chromatography, Ion Exchange; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Radioimmunoassay | 1992 |
Clinical efficacy of perindopril in hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Double-Blind Method; Drug Tolerance; Enalapril; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
[24-hour effect and tolerance for perindopril (Prestarium) in mild and moderate essential hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypertension; Indoles; Insulin; Lipids; Male; Middle Aged; Perindopril | 1992 |
Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Chi-Square Distribution; Diabetes Complications; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Blood Pressure; Captopril; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Sodium Chloride Symporter Inhibitors; Ultrasonography | 1992 |
Long-term acceptability of perindopril: European multicenter trial on 856 patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Satisfaction; Perindopril | 1992 |
Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: an efficacy, safety, and compatibility study of novel design, the Perindopril Therapeutic Safety Study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Research Design | 1992 |
A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1991 |
Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Interactions; Heart Rate; Humans; Hypertension; Indoles; Indomethacin; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Prostaglandins; Random Allocation; Renin; Thromboxane B2 | 1991 |
Long-term tolerance of perindopril in hypertensive patients with impaired renal function.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Indoles; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Perindopril | 1991 |
Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1991 |
Humoral effects of perindopril in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; Indoles; Perindopril; Renin | 1991 |
Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Humans; Hypertension; Indoles; Infusions, Intravenous; Middle Aged; Perindopril; Prodrugs | 1991 |
[Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Aorta; Blood Pressure; Cardiomegaly; Compliance; Echocardiography; Humans; Hypertension; Indoles; Perindopril; Single-Blind Method | 1991 |
Double-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Captopril; Double-Blind Method; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Vascular Resistance; Ventricular Function, Left | 1991 |
Perindopril and reference antihypertensives.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Posture | 1991 |
Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Indoles; Male; Middle Aged; Nifedipine; Perindopril; Renin-Angiotensin System | 1991 |
Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Perindopril; Renin-Angiotensin System; Spironolactone; Therapeutic Equivalency | 1991 |
The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril; Renin-Angiotensin System | 1990 |
[Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril | 1990 |
[Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 1; Humans; Hypertension; Indoles; Middle Aged; Perindopril; Time Factors | 1990 |
A double blind comparison of perindopril and atenolol in essential hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Indoles; Middle Aged; Perindopril | 1990 |
Haemodynamic effects of perindopril in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Time Factors | 1990 |
The effect of perindopril on blood pressure in humans on different sodium intakes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Sodium, Dietary | 1987 |
Pharmacokinetics of perindopril: therapeutic consequences.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Indoles; Liver Cirrhosis; Male; Middle Aged; Perindopril; Random Allocation | 1989 |
[Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Humans; Hypertension; Indoles; Middle Aged; Perindopril | 1989 |
[Perindopril: first-line treatment of arterial hypertension].
Topics: Adolescent; Adult; Aged; Amiloride; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials as Topic; Diuretics; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Random Allocation | 1989 |
[Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Random Allocation | 1989 |
Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1989 |
Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Forearm; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Pressoreceptors; Random Allocation; Reflex; Regional Blood Flow | 1989 |
Captopril versus perindopril: a double blind study in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1989 |
[Volume of the extracellular liquid and renal function during short-term administration of angiotensin converting enzyme inhibitors in essential hypertension].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Body Water; Captopril; Double-Blind Method; Extracellular Space; Female; Glomerular Filtration Rate; Humans; Hypertension; Indoles; Kidney Tubules; Male; Middle Aged; Perindopril; Random Allocation; Time Factors | 1989 |
[First intention treatment of arterial hypertension. Effectiveness and safety of perindopril].
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Indoles; Perindopril | 1989 |
Renal function, glycemic control and perindopril in diabetic patients.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Indoles; Kidney; Middle Aged; Perindopril | 1989 |
Perindopril: first-line treatment for hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Diuretics; Double-Blind Method; Humans; Hypertension; Indoles; Middle Aged; Multicenter Studies as Topic; Perindopril | 1989 |
Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System | 1989 |
Tolerance and safety of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Cough; Drug Interactions; Drug Tolerance; Humans; Hypertension; Hypotension; Indoles; Kidney; Perindopril; Potassium; Safety | 1989 |
Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cardiomegaly; Echocardiography; Female; Forearm; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Ultrasonography; Vascular Resistance | 1988 |
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Epinephrine; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Perindopril; Renin; Time Factors | 1987 |
Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Random Allocation; Signal Processing, Computer-Assisted | 1988 |
Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Arteries; Blood Flow Velocity; Blood Pressure; Brachial Artery; Compliance; Echocardiography; Female; Forearm; Heart; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardium; Perindopril; Regional Blood Flow; Vascular Resistance | 1988 |
390 other study(ies) available for perindopril and Blood Pressure, High
| Article | Year |
|---|---|
[Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Coronary Disease; Drug Combinations; Humans; Hypertension; Perindopril; Pulse Wave Analysis; Renal Insufficiency, Chronic | 2021 |
Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Canada; Drug Combinations; Humans; Hypertension; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2022 |
To study the dynamics of serum levels of vascular remodeling in patients with hypertension, including in combination with type 2 diabetes mellitus during 12‑month therapy with perindopril A.
Topics: Diabetes Mellitus, Type 2; Humans; Hypertension; Perindopril; Tissue Inhibitor of Metalloproteinase-1; Vascular Remodeling | 2022 |
DiffErenCes in AntihypertenSive Drug Blood Levels in Patients with HypertensiON (DECISION): Protocol for a Prospective Observational Study Comparing Pharmacokinetics and Pharmacodynamics Between Young and Elderly Patients.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Observational Studies as Topic; Perindopril; Prospective Studies | 2022 |
Effectiveness of indapamide/amlodipine single-pill combination in patients with isolated systolic hypertension: post-hoc analysis of the ARBALET study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2022 |
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius.
Topics: Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Madagascar; Mauritius; Perindopril; Treatment Outcome | 2022 |
Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Blood Pressure; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Perindopril | 2022 |
The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia.
Topics: Bisoprolol; Humans; Hypertension; Latvia; Medication Errors; Perindopril; Retrospective Studies | 2022 |
Perindopril prevents development of obesity and hypertension in middle aged diet-induced obese rat models of metabolic syndrome.
Topics: Animals; Blood Pressure; Diet, High-Fat; Hypertension; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Inbred WKY | 2023 |
Exploration of polymethacrylate and Hypromellose for the development of a non-sulfhydryl ACE inhibitor mucoadhesive system using Box-Behnken design: in-vitro and ex-vivo evaluation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Delayed-Action Preparations; Humans; Hypertension; Hypromellose Derivatives; Perindopril; Polymers; Tablets | 2023 |
Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies | 2023 |
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Perindopril; Retrospective Studies; Treatment Outcome | 2023 |
In the prevention of dementia, the focus should be on early and consistent treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dementia; Drug Combinations; Humans; Hypertension; Middle Aged; Perindopril | 2023 |
A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
Topics: Adult; Amlodipine; Antihypertensive Agents; Drug Combinations; Health Care Costs; Humans; Hypertension; Indapamide; Leukemia, Myeloid, Acute; Medication Adherence; Perindopril; Retrospective Studies; State Medicine | 2024 |
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Humans; Hypertension; Losartan; Perindopril; South Africa | 2023 |
Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atorvastatin; Biomarkers; Blood Pressure; Calcium Channel Blockers; Databases, Factual; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Italy; Lipids; Male; Medication Adherence; Middle Aged; Perindopril; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2019 |
[Antihypertensive Effect of Switching to a Fixed Perindopril/Amlodipine Combination in Patients Ineffectively Treated by Free Sartan-Containing Combinations. Results of the AVANGARD Study].
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Russia | 2019 |
Comparative effectiveness of combination treatment for hypertension in black Africans.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Calcium Channel Blockers; Comparative Effectiveness Research; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2020 |
Thrombospondin-1 Serum Levels In Hypertensive Patients With Endothelial Dysfunction After One Year Of Treatment With Perindopril.
Topics: Antihypertensive Agents; Blood Pressure; Echocardiography; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Thrombospondin 1 | 2019 |
Importance of fixed-dose combinations in cardiovascular prevention: the possibility of treating two diagnoses with a single pill.
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Humans; Hypertension; Perindopril | 2020 |
The impact of manual quality control review on the feasibility of central ambulatory blood pressure monitoring.
Topics: Amlodipine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Feasibility Studies; Humans; Hypertension; Indapamide; Perindopril; Quality Control | 2020 |
[Vasoprotective Effects of Prolonged Therapy With Perindopril A in Patients with Hypertension Including Concomitant Type 2 Diabetes Mellitus].
Topics: Arteries; Blood Pressure; Diabetes Mellitus, Type 2; Humans; Hyperemia; Hypertension; Perindopril | 2020 |
[Antihypertensive and Vasoprotective Effects of Combined Pharmacotherapy in Patients with Arterial Hypertension and Prediabetes].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Prediabetic State | 2020 |
[Therapeutic approaches to the Rational Use of trip-le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional tre
Topics: Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Quality of Life; Treatment Outcome | 2020 |
Euvascor - early intervention of hypertension and dyslipidaemia (dual combination of atorvastatin and perindopril).
Topics: Atorvastatin; Cardiovascular Diseases; Czech Republic; Dyslipidemias; Humans; Hypertension; Perindopril | 2020 |
Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Taurine; Treatment Outcome | 2021 |
[Comorbidity of arterial hyperten-sion and tension-type headache].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Comorbidity; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Tension-Type Headache | 2020 |
Perindopril Reduces Arterial Pressure and Does Not Inhibit Exercise-Induced Angiogenesis in Spontaneously Hypertensive Rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterial Pressure; Disease Models, Animal; Hypertension; Male; Neovascularization, Physiologic; Perindopril; Physical Exertion; Rats, Inbred SHR; Rats, Wistar | 2021 |
[Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management].
Topics: Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; Cardiovascular Diseases; Drug Combinations; Heart Disease Risk Factors; Humans; Hypertension; Perindopril; Risk Factors | 2021 |
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials.
Topics: Antihypertensive Agents; Aspirin; Blood Pressure; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indapamide; Perindopril | 2021 |
Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study.
Topics: Aged; Antihypertensive Agents; Bisoprolol; Blood Pressure; Coronary Artery Disease; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Russia; Treatment Outcome | 2021 |
Perindopril: a long-term certainty in treating hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Perindopril; Renin-Angiotensin System | 2021 |
Blood Pressure Control and Recurrent Stroke After Intracerebral Hemorrhage in 2002 to 2018 Versus 1981 to 1986: Population-Based Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; England; Female; Follow-Up Studies; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Male; Middle Aged; Perindopril; Recurrence; Risk; Risk Factors; Stroke; Survival Analysis | 2021 |
[What do we Mean by "Ideal" Blood Pressure Control?]
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Heart Failure; Humans; Hypertension; Myocardial Infarction; Perindopril | 2021 |
Case of Asymptomatic Carotid Artery Stenosis in a Hypertensive Patient.
Topics: Aged; Amlodipine; Antihypertensive Agents; Carotid Stenosis; Diuretics; Echocardiography, Doppler; Humans; Hypertension; Male; Perindopril | 2017 |
Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Drug Combinations; Drug Tolerance; Female; Greece; Humans; Hypertension; Male; Perindopril; Prospective Studies | 2017 |
The Antihypertensive Efficacy of the Triple Fixed Combination of Perindopril, Indapamide, and Amlodipine: The Results of the PETRA Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hungary; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies | 2017 |
[Adherence of Patients to Antihypertensive Therapy With Combination of Perindopril and Indapamide According to Data of the FORSAGE Program].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Medication Adherence; Perindopril; Stroke | 2017 |
[Optimization of BP Control and Arterial Elasticity With Fixed Combination Therapy Perindopril and Amlodipine In Patients With Arterial Hypertension and Increased Pulse Wave Velocity].
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diuretics; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Pulse Wave Analysis | 2017 |
Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience.
Topics: Aged; Amlodipine; Antihypertensive Agents; Australia; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Perindopril; Retrospective Studies | 2017 |
[One year persistence of free and fixed dose combinations of perindopril/amlodipine].
Topics: Amlodipine; Antihypertensive Agents; Drug Administration Schedule; Drug Combinations; Drug Prescriptions; Humans; Hungary; Hypertension; Medication Adherence; Perindopril; Survival Analysis | 2017 |
[Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Drug Combinations; Humans; Hypertension; Perindopril | 2017 |
Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hypertension; Italy; Male; Medication Adherence; Middle Aged; Outcome and Process Assessment, Health Care; Perindopril; Retrospective Studies | 2018 |
[24‑Hour Arterial Pressure Variability: Prognostic Significance, Methods of Evaluation, Effect of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Arterial Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Prognosis | 2017 |
Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Germany; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Outcome Assessment, Health Care; Perindopril; Primary Health Care; Prospective Studies | 2018 |
Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hungary; Hypertension; Indapamide; Ischemic Attack, Transient; Male; Middle Aged; Perindopril; Stroke; Treatment Outcome | 2018 |
[Assessment of Efficacy of Combined Pharmacotherapy With Fixed Perindopril/Amlodipine Combination in Patients With Combined Cardiovascular Pathology in Outpatient Practice].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Middle Aged; Outpatients; Perindopril | 2018 |
Effect of perindopril and bisoprolol on IL-2, INF-γ, hs-CRP and T-cell stimulation and correlations with blood pressure in mild and moderate hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterial Pressure; Biomarkers; Bisoprolol; C-Reactive Protein; Case-Control Studies; Female; Humans; Hypertension; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Perindopril; Severity of Illness Index; T-Lymphocytes; Time Factors; Treatment Outcome | 2018 |
[Influence of Therapy With Fixed Combination of Perindopril and Amlodipine on Parameters of Elasticity of Main Vessels and Microcirculation in Patients With Arterial Hypertension and Type 2 Diabetes Mellitus].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Elasticity; Humans; Hypertension; Microcirculation; Middle Aged; Perindopril; Pulse Wave Analysis | 2018 |
Perindopril 3.5 mg/amlodipine 2.5 mg versus renin-angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysis.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Valsartan | 2018 |
[Day-by Day Blood Pressure Variability: Methodological Aspects, Prognostic Value, Effects of Antihypertensive Therapy].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Prognosis | 2018 |
The effect of short-term perindopril and telmisartan treatment on circulating levels of anti-inflammatory cytokines in hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antihypertensive Agents; Cytokines; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan | 2018 |
[Combined Therapy of Arterial Hypertension With Triple Fixed-Dose Combination of Amlodipine/Indapamide/Perindopril Arginine in Real Clinical Practice: the Organization and the Main Results of the DOKAZATEL'STVO (Proof) Study].
Topics: Academic Medical Centers; Aged; Amlodipine; Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Patient Compliance; Perindopril; Russia | 2018 |
Topics: Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Drug Therapy, Combination; Humans; Hypertension; Myocardial Ischemia; Perindopril | 2018 |
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Prospective Studies; Treatment Outcome | 2018 |
The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Male; Obesity; Perindopril; Pulse Wave Analysis; Sleep Apnea, Obstructive | 2018 |
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Myocardial Ischemia; Perindopril | 2019 |
Effectiveness and Adherence to Treatment with Perindopril/Indapamide/Amlodipine Single-Pill Combination in a Greek Population with Hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Greece; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Prospective Studies | 2019 |
[Single Pill Indapamide and Perindopril Arginine Combination: Optimal Coupling of Vascular Protection and Hemodynamic Risk Factors Reduction in Patients with Essential Arterial Hypertension].
Topics: Antihypertensive Agents; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Retrospective Studies; Risk Factors | 2019 |
Utility of fixed-dose single tablet antihypertensive drug combinations in Cameroonians with type 2 diabetes and newly diagnosed hypertension.
Topics: Africa South of the Sahara; Amlodipine; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Tablets | 2019 |
Treatment of Hypertensive and Hypercholesterolaemic Patients with the Triple Fixed Combination of Atorvastatin, Perindopril and Amlodipine: The Results of the CORAL Study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Comorbidity; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies | 2019 |
Decreased sEng plasma levels in hypertensive patients with endothelial dysfunction under chronic treatment with Perindopril.
Topics: Antihypertensive Agents; Blood Pressure; Cross-Sectional Studies; Endoglin; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Solubility | 2019 |
In black Africans with hypertension, amlodipine-based therapy vs perindopril-hydrochlorothiazide improved BP control.
Topics: Amlodipine; Antihypertensive Agents; Black People; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Perindopril | 2019 |
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Feasibility Studies; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2019 |
[The FORTISSIMO program: advantages of fixed full dose combination of perindopril arginine and indapamide in the treatment of poorly controlled arterial hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Disease Management; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Program Development; Prospective Studies; Risk Factors; Russia; Treatment Outcome | 2013 |
Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Epithelial Sodium Channels; Eplerenone; Hypertension; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Perindopril; Renin; Sodium; Sodium Chloride, Dietary; Spironolactone; Tetrazoles | 2012 |
Twenty-four-hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed-dose combination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Prospective Studies; Young Adult | 2013 |
[Regional results of the program FORTISSIMO in Kazan].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Medication Adherence; Middle Aged; Perindopril; Program Development; Prospective Studies; Risk Factors; Russia; Treatment Outcome | 2013 |
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
Topics: Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Indapamide; Male; Perindopril | 2014 |
Inadvertent dispensing of Coumadin instead of Coversyl.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Contusions; Female; Humans; Hypertension; Medication Errors; Perindopril; Warfarin | 2013 |
Efficacy and tolerability of fixed-dose combination of perindopril/indapamide in type 2 diabetes mellitus: PICASSO trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prediabetic State; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Inadvertent dispensing of Coumadin instead of Coversyl.
Topics: Anticoagulants; Antihypertensive Agents; Contusions; Female; Humans; Hypertension; Medication Errors; Perindopril; Warfarin | 2014 |
Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2014 |
Optimum blood pressure target after lacunar stroke: con side of the argument.
Topics: Antihypertensive Agents; Blood Pressure; Endpoint Determination; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke, Lacunar | 2014 |
Optimum blood pressure target after lacunar stroke: pro side of the argument.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke, Lacunar | 2014 |
[Antihypertensive treatment for patients 80 years and older].
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Guideline Adherence; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic | 2011 |
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?
Topics: Amides; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cohort Studies; Disease-Free Survival; Drug Substitution; Enalapril; Female; Fumarates; Humans; Hypertension; Ovarian Neoplasms; Perindopril; Protein Kinase Inhibitors; Recurrence; Vascular Endothelial Growth Factor A | 2014 |
[Effect of fixed-dose combination of perindopril A/amlodipine on inter visit-to-visit and inter visit blood pressure and heart rate variability in real clinical practice in the Russian observation program KONSTANTA].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amlodipine; Blood Pressure; Blood Pressure Determination; Dose-Response Relationship, Drug; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Russia; Young Adult | 2014 |
Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Cohort Studies; Drug Prescriptions; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Mortality; Perindopril | 2014 |
Additional information regarding the SEVITENSION study.
Topics: Amlodipine; Female; Humans; Hypertension; Imidazoles; Male; Perindopril; Tetrazoles | 2014 |
[Endothelial and metabolic effects of perindopril in patients with essential hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Body Mass Index; Brachial Artery; Endothelium, Vascular; Essential Hypertension; Female; Glucose; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Perindopril; Treatment Outcome; Ultrasonography; Vasodilation; Waist Circumference | 2014 |
Perindopril for improving cardiovascular events.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Perindopril | 2014 |
Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2014 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
[Organoprotective effects of the combination of perindopril and amlodipine depending on the renal functional state in patients with arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Perindopril; Treatment Outcome | 2013 |
[Fixed dose combination perindopril-indapamide-amlodipine (Triplixam) for the treatment of arterial hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Synergism; Humans; Hypertension; Indapamide; Medication Adherence; Perindopril; Precision Medicine | 2014 |
[Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case].
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2014 |
[Hypertensive patients' adherence, motivation, and awareness during fixed-dose perindopril A and amlodipine combination treatment (results of the CONSTANTA trial)].
Topics: Aged; Amlodipine; Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Cortex; Hippocampus; Hypertension; Inflammation Mediators; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Motor Activity; Nerve Degeneration; Oxidative Stress; Peptidyl-Dipeptidase A; Perindopril; Rats | 2015 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Female; Humans; Hypertension; Male; Perindopril | 2015 |
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Topics: Amlodipine; Amlodipine, Valsartan Drug Combination; Antihypertensive Agents; Female; Humans; Hypertension; Male; Perindopril | 2015 |
[Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Risk Factors; Russia; Treatment Outcome | 2015 |
Evaluation of patients diagnosed with essential arterial hypertension through network analysis.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Nebivolol; Perindopril; Prospective Studies; Tetrazoles | 2016 |
[The Fixed Combination of Perindopril A/Amlodipine--a Rational Choice to Improve the Control of Hypertension in Clinical Practice (Results of the Program KONSTANT observational program)].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Perindopril arginine + amlodipine for the treatment of hypertension in the USA.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; United States | 2015 |
Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Female; General Practice; Humans; Hypertension; Male; Middle Aged; Observer Variation; Office Visits; Perindopril; Predictive Value of Tests; Reproducibility of Results; Russia; Time Factors; Treatment Outcome | 2015 |
Severe jaundice due to intrahepatic cholestasis after initiating anticoagulation with rivaroxaban.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Cholestasis, Intrahepatic; Humans; Hypertension; Jaundice; Liver; Male; Perindopril; Propanolamines; Rivaroxaban; Severity of Illness Index; Treatment Outcome | 2016 |
[EFFECTIVENESS OF FIXED COMBINATION OF PERINDOPRILARGININE AND AMLODIPINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC CARDIAC INSUFFICIENCY AND SIGNS OF CHRONIC KIDNEY DISEASE].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Monitoring; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Kidney Function Tests; Male; Middle Aged; Perindopril; Prospective Studies; Renal Insufficiency, Chronic; Russia; Severity of Illness Index; Treatment Outcome | 2015 |
[Therapy of Arterial Hypertension in Patients With Chronic Heart Failure and Signs of Chronic Kidney Disease With Fixed Perindopril/Amlodipine Combination].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Essential Hypertension; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Treatment Outcome | 2015 |
The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cohort Studies; Drug Combinations; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Saudi Arabia; Treatment Outcome | 2016 |
Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Cell Line, Tumor; Hep G2 Cells; Humans; Hypertension; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Perindopril; Renin-Angiotensin System; Resistin; Toll-Like Receptor 4; Transcription Factor RelA | 2016 |
[New fixed dose combination for initial control of hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Perindopril | 2016 |
Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Humans; Hypertension; Longitudinal Studies; Male; Middle Aged; Perindopril; Prospective Studies; Risk Factors | 2016 |
[The Possibilities of Pharmacological Correction of Endothelial Dysfunction in Patients With Arterial Hypertension].
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
[The Results of Long-Term Observation of Patients Who Participated in the ADVANCE Trial].
Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2015 |
Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2016 |
Efficacy and Safety Assessment of Hypertension Management with Coveram (Perindopril/Amlodipine Fixed Combination) in Patients with Previous Angiotensin Receptor Blocker (ARB) Treatment: Arabian Gulf STRONG Study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Drug Substitution; Female; Humans; Hypertension; Male; Middle Aged; Middle East; Perindopril; Time Factors; Treatment Outcome | 2016 |
Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Combinations; Drug Resistance; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2017 |
Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Lipids; Male; Middle Aged; Perindopril; Risk Factors; Time Factors; Treatment Outcome; Ukraine | 2017 |
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypertension; Hypotension; Indapamide; Male; Medication Adherence; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stroke | 2017 |
Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Endothelium, Vascular; Humans; Hypertension; Perindopril; Thrombospondin 1; Treatment Outcome | 2017 |
[Optimization of Control of Blood Pressure, Metabolic Disorders and Target Organs Protection With Fixed Perindopril and Indapamide Combination in Treated Patients With Arterial Hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Humans; Hypertension; Indapamide; Metabolic Diseases; Perindopril; Pulse Wave Analysis | 2017 |
[Efficacy and Safety of a Fixed Combination of Perindopril Arginine and Amlodipine in Patients With Hypertension Uncontrolled by Treatment With Angiotensin II Receptor Blockers in Real Clinical Practice. Results of the PREVOSHODSTVO (SUPERIORITY) Program]
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Arginine; Blood Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Treatment Outcome | 2017 |
[How to Increase the Effectiveness of Antihypertensive Therapy in Clinical Practice: Results of the Russian Observational Program FORSAZH].
Topics: Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Russia | 2016 |
[Effectiveness of Dispersible Forms of Perindipril in Patients With Uncontrolled Arterial Hypertension in Clinical Practice].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diuretics; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2016 |
[The Use of Fixed Perindopril A/Amlodipine Combination Provides High Compliance to Therapy, Effective and Safe Arterial Pressure Lowering in Patients With Previous Inefferctive Therapy. The POTENTIAL Program].
Topics: Amlodipine; Antihypertensive Agents; Arterial Pressure; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Perindopril; Treatment Outcome | 2015 |
[Evaluation of Antihypertensive Efficacy and Patient Adherence to Treatment With the New Formulation Perindopril Arginine (Orally Disintegrating Tablet) in General Clinical Practice: OPTIMUM Program].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Perindopril; Program Evaluation | 2016 |
[Survival advantage also in over 80-year-old patients].
Topics: Aged, 80 and over; Antihypertensive Agents; Germany; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2008 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin-converting enzyme inhibitor therapy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Female; Genotype; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Perindopril; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin | 2008 |
[Need of antihypertensive therapy in patients aged 80 years or more].
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Treatment Outcome | 2008 |
Older age should not be a barrier to the treatment of hypertension.
Topics: Age Factors; Aged, 80 and over; Aging; Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Patient Selection; Perindopril; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2008 |
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Double-Blind Method; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Losartan; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
[Treatment of hypertension in people over 80 years should not be discontinued].
Topics: Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cause of Death; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2008 |
Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures.
Topics: Acetazolamide; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diuretics; Female; Humans; Hypertension; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Middle Aged; Perindopril; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
[Hypertension--does it matter how blood pressure is lowered?].
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome | 2008 |
Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cross-Sectional Studies; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2008 |
You should treat patients over the age of 80 who have hypertension.
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2008 |
Secondary prevention of coronary disease with ACE inhibition--does blood pressure reduction with perindopril explain the benefits in EUROPA?
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Perindopril; Proteinuria; Rats | 2008 |
[Effect of perindopril on cognitive functions in young and middle aged patients with hypertensive disease].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cognition; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Psychometrics; Treatment Outcome | 2008 |
[Perindopril arginin: novel drug form of a well known Angiotensin converting enzyme inhibitor].
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Myocardial Infarction; Perindopril; Survival Rate | 2008 |
[Arterial hypertension in persons older than 80 years: the problem can be successfully solved].
Topics: Age Factors; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Confidence Intervals; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Indapamide; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2008 |
[Treatment of hypertensive patients of 80 years of age or older].
Topics: Aged, 80 and over; Antihypertensive Agents; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2008 |
Controversy in treating the oldest old with hypertension: is the hypertension in the very elderly trial the final answer?
Topics: Aged, 80 and over; Antihypertensive Agents; Data Interpretation, Statistical; Female; Frail Elderly; Humans; Hypertension; Indapamide; Male; Perindopril; Randomized Controlled Trials as Topic; Stroke; Survival Analysis; Treatment Outcome | 2009 |
Baseline characteristics of participants in the Hypertension in the Very Elderly Trial (HYVET).
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Anthropometry; Blood Glucose; Cholesterol, HDL; Comorbidity; Creatinine; Female; Hematocrit; Hemoglobins; Humans; Hypertension; Indapamide; Lipids; Male; Patient Selection; Perindopril; Randomized Controlled Trials as Topic; Smoking; Urea; Uric Acid | 2009 |
[Effect of antihypertensive drugs on some humoral parameters of endothelial function].
Topics: Aged; Antihypertensive Agents; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Follow-Up Studies; Humans; Hypertension; Indapamide; Middle Aged; Nitrous Oxide; Perindopril; Treatment Outcome; Vasodilation | 2009 |
Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice.
Topics: Blood Pressure; Diabetes Mellitus; Humans; Hypertension; Indapamide; Perindopril | 2009 |
Heart protection: a key target in the management of patients with diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Indapamide; Perindopril | 2009 |
Perindopril decreases P wave dispersion in patients with stage 1 hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Echocardiography; Humans; Hypertension; Male; Middle Aged; Perindopril | 2009 |
[Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease].
Topics: Administration, Oral; Amlodipine; Antihypertensive Agents; Coronary Disease; Drug Combinations; Humans; Hypertension; Perindopril; Treatment Outcome | 2009 |
[Treatment of hypertension in patients older than 80 years].
Topics: Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Kaplan-Meier Estimate; Male; Perindopril; Stroke | 2009 |
How controlling of hypertension might matter.
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cilazapril; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Insulin; Lipids; Perindopril; Time Factors; Treatment Outcome | 2009 |
[Use of prestarium (perindopril) in patients with polymorbidity syndrome (AH, DM, nephropathy)].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Perindopril; Renal Insufficiency; Treatment Outcome | 2009 |
[An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension].
Topics: Ambulatory Care; Amides; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fumarates; Humans; Hypertension; Male; Middle Aged; Obesity, Abdominal; Perindopril; Ramipril; Renin; Time Factors | 2010 |
Efficacy and safety of diuretics in combination with perindopril in hypertensive stroke patients: Results of the Japan Perindopril and Diuretics on Cerebrovascular Disease Study (J-PADOC).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Stroke | 2010 |
Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Hypertension; Mesenteric Arteries; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
[Comparative efficacy of a fixed combination perindopril/ indapamide in arterial hypertension patients of various sexes and ages].
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diuretics; Drug Combinations; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Male; Middle Aged; Perindopril; Sex Factors; Treatment Outcome; Ultrasonography; Young Adult | 2010 |
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.
Topics: Age Factors; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Confounding Factors, Epidemiologic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Racial Groups; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome | 2010 |
[Efficacy of traditional therapy and chronotherapy using prestarium in elderly patients with polymorbid syndrome].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Drug Chronotherapy; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Syndrome | 2010 |
Durable improvement of renal function after perindopril withdrawal in Lyon hypertensive rats.
Topics: Animals; Blood Pressure; Hypertension; Kidney; Kidney Function Tests; Male; Perindopril; Random Allocation; Rats | 2011 |
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.
Topics: Antihypertensive Agents; Aorta; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Drug Therapy, Combination; Elasticity; Humans; Hypertension; Indapamide; Perindopril; Risk Factors; Treatment Outcome | 2011 |
Dose-dependent antihypertensive efficacy and tolerability of perindopril in a large, observational, 12-week, general practice-based study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Perindopril; Prospective Studies | 2011 |
[Elevation of compliance and motivation to antihypertensive therapy in patients with arterial hypertension by way of educational programs and rational use of angiotensin converting enzyme perindopril. Results of the PRISMA study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Asymptomatic Diseases; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Clinical Competence; Delivery of Health Care; Female; Humans; Hypertension; Life Style; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Perindopril; Preventive Health Services; Program Evaluation; Risk Factors | 2010 |
Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Calcium Channel Blockers; Confidence Intervals; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Renin-Angiotensin System; Research Design; Severity of Illness Index; Tetrazoles | 2011 |
[Combination of perindopril and amlodipine as optimal basis for realization of desirable clinical effects in the treatment of arterial hypertension with fixed drug combination].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Drug Combinations; Drug Synergism; Heart Rate; Humans; Hypertension; Microcirculation; Myocardial Ischemia; Perindopril; Renin-Angiotensin System; Secondary Prevention; Vasomotor System | 2011 |
[Blood pressure therapy - differential therapeutic solutions. Fixed combination improves prognosis of hypertensive patients].
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2011 |
Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Physiological Phenomena; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Kidney; Male; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2011 |
Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chi-Square Distribution; Diuretics; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Slovakia; Time Factors; Treatment Outcome | 2011 |
[Pharmaco-economical aspects of treatment of patients with arterial hypertension with fixed perindopril/amlodipine combination].
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Costs and Cost Analysis; Drug Combinations; Drug Synergism; Female; Humans; Hypertension; Male; Medication Therapy Management; Middle Aged; Perindopril; Secondary Prevention; Treatment Outcome | 2011 |
[Efficiency perindopril at patients with arterial hypertension and obesity].
Topics: Adipose Tissue; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Mass Index; Drug Monitoring; Enalapril; Female; Heart Function Tests; Humans; Hypertension; Insulin Resistance; Kidney Function Tests; Male; Metabolism; Middle Aged; Obesity; Perindopril; Protective Agents; Therapeutic Equivalency; Treatment Outcome | 2011 |
[Estimation of antihypertension efficiency and use of fixed combination perindopril+amlodipin by uncontrollable hypertension patients within the limits of routine treatment].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Biological Availability; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Resistance; Drug Synergism; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Severity of Illness Index; Treatment Outcome | 2011 |
Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Heart Failure; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred Dahl; Vascular Endothelial Growth Factor A | 2011 |
A new dimension in hypertension management with the amlodipine/perindopril combination.
Topics: Amlodipine; Antihypertensive Agents; Humans; Hypertension; Perindopril; Randomized Controlled Trials as Topic; Treatment Failure | 2011 |
[Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome].
Topics: Antihypertensive Agents; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Middle Aged; Perindopril | 2011 |
Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Hypertension; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephrosclerosis; Peptidyl-Dipeptidase A; Perindopril; Rats; Renin-Angiotensin System; Transgenes | 2012 |
Antihypertensives in octogenarians.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Severity of Illness Index | 2012 |
[Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2011 |
Short-term antihypertensive therapy lowers the C-reactive protein level.
Topics: Adult; Antihypertensive Agents; Biomarkers; Bisoprolol; Blood Pressure; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril | 2012 |
Modeling of angiotensin II-angiotensin-(1-7) counterbalance in disease progression in spontaneously hypertensive rats treated with/without perindopril.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Male; Models, Biological; Peptide Fragments; Perindopril; Rats; Rats, Inbred SHR | 2012 |
Chronic reduction of nitric oxide level in adult spontaneously hypertensive rats induces aortic stiffness similar to old spontaneously hypertensive rats.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Clonidine; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Stiffness | 2012 |
Persistent effect of early, brief angiotensin-converting enzyme inhibition on segmental pressure dependency of aortic stiffness in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Heart Rate; Hypertension; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Stiffness | 2012 |
Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Bradykinin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypertension; Laryngeal Diseases; Male; Perindopril; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
[Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension].
Topics: Administration, Oral; Antihypertensive Agents; Arteries; Biological Availability; Blood Pressure; Drug Combinations; Drug Synergism; Endothelium, Vascular; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Pulse Wave Analysis; Treatment Outcome; Vascular Resistance; Vasodilation | 2012 |
[Antihypertensive therapy and dynamics of vascular wall rigidity in elderly patients with non-valvular atrial fibrillation].
Topics: Aged; Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Arterial Pressure; Arteries; Atrial Fibrillation; Combined Modality Therapy; Drug Monitoring; Female; Fluorobenzenes; Humans; Hypertension; Male; Myocardial Infarction; Perindopril; Pulse Wave Analysis; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Tetrazoles; Treatment Outcome; Ultrasonography, Doppler, Duplex; Valine; Valsartan; Vascular Resistance | 2012 |
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Immunoassay; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Perindopril; Renin-Angiotensin System; von Willebrand Factor | 2002 |
[The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Depressive Disorder; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Middle Aged; Perindopril; Propranolol; Thiazepines; Time Factors; Treatment Outcome | 2002 |
[Clinical assessment of efficacy and safety of noliprel in patients with hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2002 |
[Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
Topics: Adult; Aged; Albumins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Body Mass Index; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Pulse; Risk Factors | 2002 |
Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diuretics; Heart; Hypertension; Indapamide; Male; Myocardium; Obesity; Perindopril; Rats; Rats, Zucker; Ventricular Function, Left | 2003 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hypertension; Indapamide; Ischemic Attack, Transient; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Recurrence; Stroke; Treatment Outcome | 2003 |
Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is the key.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Stroke; Ventricular Remodeling | 2003 |
Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Renin-Angiotensin System; Stroke | 2003 |
Perindopril and candesartan comparative efficacy and safety in type II diabetic hypertensive patients.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Perindopril; Tetrazoles; Treatment Outcome | 2003 |
[Management of dementia and cognitive functions in patients after cerebrovascular stroke: new results from the PROGRESS study].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Dementia; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2003 |
Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Topics: Adrenergic alpha-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Perindopril; Rilmenidine | 2003 |
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertension; Immunohistochemistry; Kidney; Male; Membrane Proteins; Peptidyl-Dipeptidase A; Perindopril; Proteins; Rats; Rats, Inbred SHR; Reference Values | 2003 |
[Americans demand stricter blood pressure control. Does 120/80 already need to be treated?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Diastole; Diuretics; Drug Therapy, Combination; Germany; Humans; Hypertension; Indapamide; Life Style; Middle Aged; Perindopril; Risk Factors; Sodium Chloride Symporter Inhibitors; Systole; United States | 2003 |
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cognition Disorders; Dementia; Female; Genotype; Humans; Hypertension; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Perindopril; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Sequence Deletion; Statistics as Topic; Stroke; Survival Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2003 |
Clinical implications of PROGRESS: questions and answers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Perindopril; Secondary Prevention; Stroke | 2003 |
PROGRESS results: implementation in stroke guidelines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Health Plan Implementation; Humans; Hypertension; Perindopril; Practice Guidelines as Topic; Preventive Medicine; Risk Factors; Secondary Prevention; Stroke | 2003 |
[Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Humans; Hypertension; Perindopril; Risk Factors | 2003 |
Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetic Nephropathies; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Renin; Signal Processing, Computer-Assisted; Sympathetic Nervous System | 2004 |
[Newly diagnosed hypertensive. It calls for treatment immediately with a combination ].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Patient Compliance; Perindopril | 2003 |
Secondary prevention for stroke and transient ischaemic attacks.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypercholesterolemia; Hypertension; Indapamide; Ischemic Attack, Transient; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2004 |
Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Topics: Administration, Oral; Angiotensin I; Animals; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Infusions, Intravenous; Male; Pericardial Effusion; Perindopril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Pressure | 2003 |
Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Stroke | 2004 |
[Effect of fixed low dose combination of perindopril and indapamide on processes of cardiovascular remodeling in previously untreated patients with hypertension].
Topics: Antihypertensive Agents; Blood Pressure; Carotid Intima-Media Thickness; Humans; Hypertension; Indapamide; Perindopril; Pulse Wave Analysis | 2004 |
[The benefit of a fixed combination of antihypertensives in hypertension treatment].
Topics: Antihypertensive Agents; Diuretics; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2004 |
Reduced renal ClC-5 Cl- channel expression in spontaneously hypertensive rats with microalbuminuria.
Topics: Albuminuria; Animals; Chloride Channels; Gene Expression Regulation; Hypertension; Kidney Cortex; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2004 |
[Assessment of effects of angiotensin converting enzyme inhibitor perindopril on function of endothelium of arterial vessels in patients with ischemic heart disease and hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Brachial Artery; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Endothelins; Endothelium, Vascular; Epoprostenol; Female; Humans; Hypertension; Male; Myocardial Ischemia; Nitric Oxide; Perindopril; Thromboxanes; Time Factors; Vasodilation | 2004 |
[Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Diastole; Diuretics; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Systole; Time Factors; Treatment Outcome | 2004 |
Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Blood Vessels; Body Weight; Capsaicin; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Telmisartan | 2004 |
The PROGRESS trial three years later: time for a balanced report of effectiveness.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke | 2004 |
The PROGRESS trial three years later: time for more action, less distraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Data Interpretation, Statistical; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke | 2004 |
Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Cerebrovascular Disorders; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Perindopril; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Stroke | 2005 |
The PROGRESS trial three years later: HOPE trial may shed some light.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Randomized Controlled Trials as Topic; Stroke | 2004 |
[The drug of the month: a new antihypertensive association: Preterax, low doses of ACE inhibitor and thiazide in the same pill].
Topics: Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Remission Induction; Time Factors | 2004 |
Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Fibrinogen; Genetic Predisposition to Disease; Hemostasis; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Perindopril; Phenotype; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Treatment Outcome | 2004 |
[Level of endothelial vasodilatation and activity of angiotensin converting enzyme as criterion of efficacy of therapy in patients with mild and moderate hypertension].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Brachial Artery; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler; Vasodilation | 2005 |
[Effect of low dose combination of antihypertensive drugs on the state of microcirculation].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Perindopril; Prospective Studies; Treatment Outcome | 2005 |
Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Therapy, Combination; Hypertension; Kidney; Losartan; Male; Perindopril; Rats; Renin-Angiotensin System | 2005 |
C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; C-Reactive Protein; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Predictive Value of Tests; Retrospective Studies; Treatment Outcome | 2005 |
[Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen Type I; Collagen Type III; Female; Hypertension; Kidney; Male; Nephrosclerosis; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
[Comparison of therapeutic strategies in the management of hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; France; Humans; Hypertension; Indapamide; Perindopril | 2005 |
[Vascular impact of anti-hypertensive treatment and renal protection].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Double-Blind Method; France; Humans; Hypertension; Indapamide; Kidney Diseases; Perindopril | 2005 |
What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Administration Schedule; Drug Combinations; Heart Diseases; Humans; Hypertension; Indapamide; Kidney Diseases; Perindopril | 2005 |
[ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Doxazosin; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2005 |
Idiosyncratic pancreatitis associated with perindopril.
Topics: Aged; Amylases; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Pancreatitis; Perindopril; Treatment Outcome | 2005 |
[ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Antihypertensive Agents; Cardiovascular Diseases; Contraindications; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy.
Topics: Animals; Biphenyl Compounds; Calcineurin; Calcium-Transporting ATPases; Cardiomegaly; Disease Models, Animal; Drug Combinations; Heart; Hypertension; Irbesartan; Male; Myocardium; Myocytes, Cardiac; Perindopril; Pressure; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Tetrazoles | 2006 |
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Blotting, Western; DNA, Complementary; Female; Gene Expression Regulation; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Proteins; Proteinuria; Rats; Renin-Angiotensin System | 2006 |
Production of nitric oxide, lipid peroxidation and oxidase activity of ceruloplasmin in blood of elderly patients with primary hypertension. Effects of perindopril treatment.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Ceruloplasmin; Humans; Hypertension; Lipid Peroxidation; Malondialdehyde; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Perindopril; Renin-Angiotensin System | 2006 |
Concurrent dolichoectasia of basilar and coronary arteries.
Topics: Age of Onset; Aged; Aged, 80 and over; Antihypertensive Agents; Basilar Artery; Celiprolol; Coronary Disease; Coronary Vessels; Dilatation, Pathologic; Female; Genetic Predisposition to Disease; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Stroke | 2006 |
Results of the ASCOT-BPLA trial: no practical implications for treatment of hypertension.
Topics: Amlodipine; Atenolol; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 2006 |
[Prestarium in patients with arterial hypertension and ischemic heart disease (or risk factors) -- safe achievement of target blood pressure level (the PREMIERA study)].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Follow-Up Studies; Humans; Hypertension; Middle Aged; Myocardial Ischemia; Perindopril; Prospective Studies; Quality of Life; Risk Factors; Treatment Outcome | 2006 |
[Cerebral and myocardial perfusion in patients with arterial hypertension and metabolic syndrome after monotherapy with combined drug noliprel].
Topics: Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Circulation; Coronary Circulation; Diuretics; Drug Combinations; Female; Heart; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Perindopril; Radionuclide Imaging; Treatment Outcome | 2006 |
[Effect of perindopril on indices of cardiac function and quality of life in patients with arterial hypertension in regard to age].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Echocardiography, Doppler; Follow-Up Studies; Humans; Hypertension; Perindopril; Treatment Outcome | 2006 |
Letter by Safar and Fournier regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study".
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Indapamide; Perindopril; Proportional Hazards Models; Reproducibility of Results; Stroke Volume; Treatment Outcome | 2006 |
Urinary zinc excretion is normalized in primary arterial hypertension after perindopril treatment.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Female; Humans; Hypertension; Male; Perindopril; Zinc | 2006 |
Pulse pressure: a help in medical semiology for metabolic syndrome.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Blood Pressure Determination; Heart Rate; Humans; Hypertension; Metabolic Syndrome; Perindopril; Pulse | 2007 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
Effects of angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Exercise Test; Hypertension; Lactates; Male; Muscle, Skeletal; Perindopril; Physical Conditioning, Animal; Physical Fitness; Rats; Rats, Inbred SHR | 2007 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
[Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic; Time Factors | 2007 |
[Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Diuretics; Family Practice; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2007 |
Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats.
Topics: Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Eating; Fatty Acids, Omega-3; Hypertension; Male; Perindopril; Rats; Renin | 2008 |
[Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cell Membrane; Endothelium, Vascular; Female; Homeostasis; Humans; Hypertension; Male; Middle Aged; Perindopril; Renin-Angiotensin System | 2007 |
New drug combo lowers blood pressure: all diabetics benefit. Two drugs offer lifesaving benefits, even in diabetes with normal blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Angiopathies; Diabetic Retinopathy; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2007 |
Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; Chi-Square Distribution; Female; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Perindopril; Renin-Angiotensin System; Statistics, Nonparametric; Telmisartan; Thrombosis | 2008 |
Advances in reducing the burden of vascular disease in type 2 diabetes.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Middle Aged; Perindopril | 2008 |
Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, CD34; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Femoral Artery; Hematopoietic Stem Cells; Hypertension; Indapamide; Male; Muscle, Skeletal; Neovascularization, Physiologic; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Perindopril; Proto-Oncogene Proteins c-kit; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Endothelial Growth Factor A | 2008 |
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2008 |
Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; France; Hospitals, University; Humans; Hypertension; Indapamide; Interviews as Topic; Ischemic Attack, Transient; Male; Perindopril; Probability; Prognosis; Prospective Studies; Stroke | 2008 |
Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Kidney Medulla; Male; Nitric Oxide; Perindopril; Rats | 2008 |
Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Cells; Cell Differentiation; Disease Models, Animal; Endothelium, Vascular; Hindlimb; Hydralazine; Hypertension; Ischemia; Ligation; Losartan; Male; Neovascularization, Physiologic; Oxidative Stress; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stem Cells | 2008 |
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System | 2008 |
[Changes of elastic properties of peripheral vessels and parameters of endothelial function at the background of the use of fixed combination of perindopril and indapamide in patients with hypertensive disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brachial Artery; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Elasticity; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypertension; Immunoassay; Indapamide; Male; Middle Aged; Oscillometry; Perindopril; Time Factors; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2008 |
[Type 2 diabetes. Routine ACE inhibitors?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2008 |
Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Indoles; Perindopril; Skin; Tunica Media | 1995 |
Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cerebrovascular Disorders; Cyclic GMP; Epoprostenol; Heart; Hypertension; Hypertrophy, Left Ventricular; Indoles; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Ventricular Pressure | 1995 |
Aortic stiffness and left ventricular mass in a rat model of isolated systolic hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Aorta, Thoracic; Calcium, Dietary; Cholecalciferol; Data Interpretation, Statistical; Elasticity; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Indoles; Male; Nicotine; Perindopril; Placebos; Random Allocation; Rats; Rats, Wistar; Renin; Systole | 1995 |
Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cerebrovascular Disorders; Coronary Circulation; Creatine Kinase; Cyclic GMP; Disease Models, Animal; Glycogen; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Indoles; L-Lactate Dehydrogenase; Myocardium; Perindopril; Rats; Rats, Inbred SHR | 1994 |
The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Aorta; Blood Pressure; Cell Nucleus; Cells, Cultured; Female; Flow Cytometry; Heart Rate; Hypertension; Indoles; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin | 1995 |
Perindopril treatment prolonged the lifespan of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Disease Models, Animal; Hemodynamics; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Treatment Outcome | 1995 |
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Indoles; Kidney Diseases; Male; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; Renin | 1995 |
[Concentration of free intracellular magnesium in the myocardium of spontaneously hypertensive rats treated chronically with calcium antagonist or angiotensin converting enzyme inhibitor].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Hypertension; Indoles; Magnesium; Male; Myocardium; Nitrendipine; Perindopril; Rats; Rats, Inbred Strains | 1994 |
Effects of perindopril on hypertension and stroke prevention in experimental animals.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hypertension; Indoles; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
ACE inhibitors and cough.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cough; Enalapril; Female; Humans; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Perindopril; Retrospective Studies | 1994 |
Perindopril changes the mesenteric pressure profile of conscious hypertensive and normotensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Indoles; Mesenteric Arteries; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance | 1994 |
Dose-dependent effects of perindopril on blood pressure and small-artery structure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole | 1993 |
Effect of perindopril on cardiovascular hypertrophy of the SHR: respective roles of reduced blood pressure and reduced angiotensin II levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR | 1993 |
Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arteries; Blood Pressure Monitors; Carotid Arteries; Compliance; Hemodynamics; Hypertension; Hypertrophy; Image Processing, Computer-Assisted; Indoles; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Vascular Resistance | 1993 |
Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Topics: Animals; Blood Pressure; Blood Vessels; Body Weight; Cardiomegaly; Cerebrovascular Disorders; Drinking; Heart Rate; Hypertension; Hypertrophy; Indoles; Male; Perindopril; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex | 1993 |
Vascular remodeling in systemic hypertension.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclic GMP; Hypertension; Indoles; Muscle, Smooth, Vascular; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Vasoconstriction; Vasodilation | 1993 |
Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Sodium | 1993 |
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Decerebrate State; Hemodynamics; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Vasoconstriction | 1995 |
Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Hypertension; Indoles; Male; Peptide Fragments; Perindopril; Radioimmunoassay; Rats; Rats, Inbred SHR; Renin; Tissue Distribution | 1995 |
Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Creatinine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Indoles; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies; Proteinuria; Sodium | 1995 |
Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiomegaly; Female; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Polyploidy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine.
Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Arginine; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; Hypertension; Indoles; Isoquinolines; Mesenteric Arteries; Nitroarginine; Perindopril; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Vasodilation | 1996 |
In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Hypertension; Indoles; Kidney; Male; Natriuresis; Perfusion; Perindopril; Pressure; Rats; Rats, Inbred Strains; Receptors, Thromboxane; Reference Values; Renal Circulation; Time Factors; Vasoconstriction | 1996 |
Cardiac transplantation, perindopril, and left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Heart Transplantation; Hypertension; Hypertrophy, Left Ventricular; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR | 1996 |
Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Topics: Adrenal Glands; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antibodies; Blood Pressure; Hypertension; Indoles; Kidney; Male; Mice; Perindopril; Rats; Renin; Renin-Angiotensin System | 1995 |
Peripheral vasculature in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Vessels; Humans; Hypertension; Indoles; Perindopril; Vascular Resistance | 1996 |
Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carotid Arteries; Diuretics; Drug Therapy, Combination; Hemodynamics; Hypertension; In Vitro Techniques; Indapamide; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Serotonin; Vasoconstriction | 1996 |
Perindopril treatment in the prevention of stroke in experimental animals.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR | 1996 |
The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Endothelium, Vascular; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Indoles; Male; Muscle Relaxation; Nitric Oxide Synthase; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity | 1997 |
Brief treatment of SHR with an ace inhibitor fails to cause long-term normotension but markedly increases mortality.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Indoles; Longevity; Perindopril; Rats; Rats, Inbred SHR; Substance Withdrawal Syndrome | 1995 |
From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Indoles; Perindopril | 1996 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1997 |
Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Brain; Cerebral Cortex; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Kidney; Kidney Diseases; Male; Perindopril; Prospective Studies; Rats; Rats, Inbred SHR; Survival Rate; Time Factors | 1997 |
Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Indoles; Male; Norepinephrine; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors | 1997 |
Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Kidney Glomerulus; Kidney Tubules; Male; Obesity; Perindopril; Rats; Rats, Inbred SHR; Reserpine; Time Factors | 1997 |
Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiac Output; Enzyme Precursors; Heart Rate; Hemodynamics; Hypertension; Indoles; Kidney Cortex; Male; Perindopril; Rats; Rats, Inbred Strains; Regional Blood Flow; Renin; Renin-Angiotensin System; Vascular Resistance | 1997 |
Renal amylin binding in normotensive and hypertensive rats: effects of angiotensin converting enzyme inhibition with perindopril.
Topics: Amyloid; Angiotensin-Converting Enzyme Inhibitors; Animals; Hypertension; Indoles; Islet Amyloid Polypeptide; Kidney; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Renin | 1997 |
Lingual angioedema after perindopril use.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Indoles; Macroglossia; Middle Aged; Perindopril | 1998 |
Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Glomerular Filtration Rate; Hemodynamics; Hypertension; Indoles; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Renal Artery; Vasoconstrictor Agents | 1998 |
[Comparative efficacy of and tolerance to prestarium and lomir in long-term treatment of hypertensive subjects].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Isradipine; Male; Middle Aged; Perindopril; Treatment Outcome | 1998 |
Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cohort Studies; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Product Surveillance, Postmarketing | 1998 |
Mechanisms of spontaneous baroreflex impairment in lyon hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Indoles; Losartan; Male; Perindopril; Rats | 1998 |
ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; Bradycardia; Cardiomegaly; Heart Rate; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity; Weight Gain | 1998 |
Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Glycogen; Heart; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR | 1998 |
Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Imidazoles; Indoles; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles | 1998 |
[Long-term monotherapy with prestarium, anap and lomir in patients with mild and moderate arterial hypertension: clinical efficacy, hemodynamics and morphofunctional parameters of heart].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Azides; Blood Pressure; Calcium Channel Blockers; Echocardiography; Enkephalin, Leucine-2-Alanine; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Indoles; Isradipine; Male; Middle Aged; Perindopril; Treatment Outcome; Vascular Resistance | 1998 |
[Prestarium treatment of essential hypertension].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Electrocardiography; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Renal Circulation; Treatment Outcome; Vascular Resistance | 1998 |
[Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
Topics: Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril | 1997 |
Effects of L-type calcium channel activation on renal vascular resistances in the Lyon hypertensive rat.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Agonists; Calcium Channels; Hypertension; In Vitro Techniques; Indoles; Kidney; Kidney Function Tests; Male; Perindopril; Rats; Vascular Resistance | 1999 |
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Cell Nucleus; Diastole; DNA; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Losartan; Lymphocytes; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Perindopril; Rats; Rats, Inbred SHR; Systole; Telemetry; Time Factors | 1999 |
Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the prague hypertensive rat.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Genetic Predisposition to Disease; Hypertension; Indoles; Losartan; Male; Perindopril; Rats; Rats, Inbred Strains; Time Factors | 1998 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pressure; Brain; Edetic Acid; Hypertension; Hypertrophy; Indoles; Male; Perindopril; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stress, Physiological | 1999 |
Fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination in very elderly hypertensives.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertension; Indapamide; Indoles; Middle Aged; Perindopril; Treatment Outcome | 1999 |
Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Exercise Therapy; Heart Failure; Humans; Hypertension; Hypotension; Indoles; Perindopril | 1999 |
Different effects of antihypertensive agents on cardiac and vascular hypertrophy in the transgenic rat line TGR(mRen2)27.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Aorta, Thoracic; Aortic Diseases; Cardiomegaly; Cell Cycle; DNA; Drug Therapy, Combination; Female; Flow Cytometry; Follow-Up Studies; Heart Ventricles; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertrophy; Indoles; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Transgenes | 1999 |
Low dose indapamide plus perindopril combination effects on cardiovascular structure and function in genetic hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Drug Therapy, Combination; Hypertension; Indapamide; Male; Perindopril; Rats; Rats, Inbred SHR | 1999 |
Evaluation of high through-to-peak ratio of perindopril in SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Enalapril; Heart Rate; Hypertension; Indoles; Isoquinolines; Locomotion; Male; Perindopril; Quinapril; Random Allocation; Rats; Rats, Inbred SHR; Telemetry; Tetrahydroisoquinolines | 1999 |
A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
Topics: Acrylates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Contraindications; Double-Blind Method; Half-Life; Humans; Hypertension; Imidazoles; Perindopril; Telmisartan; Thiophenes | 1999 |
The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pressure; Capillaries; Coronary Vessels; Diuretics; Drug Synergism; Heart; Hypertension; Indapamide; Male; Myocardium; Perindopril; Rats; Rats, Inbred SHR | 2000 |
Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Aorta; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Bradykinin; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Heart Ventricles; Hypertension; Myocardium; Organ Size; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Stroke; Tetrazoles | 2000 |
Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diastole; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Kidney Cortex; Male; Norepinephrine; Perindopril; Rats; Renin; Renin-Angiotensin System; Sodium; Systole; Time Factors | 2000 |
Effects of perindopril on vascular wall and left ventricular hypertrophy in rats with experimental hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Hypertension; Hypertrophy, Left Ventricular; Male; Mesenteric Artery, Superior; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |
Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Viscosity; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Imidazoles; Losartan; Mesenteric Arteries; Muscle Tonus; Perindopril; Phenylpropionates; Pyridines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Splanchnic Circulation; Vascular Resistance; Vasodilation | 2000 |
Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiac Volume; Diastole; Echocardiography, Doppler, Pulsed; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Ventricular Function, Left | 2000 |
[Chest pain potentially induced by perindopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chest Pain; Humans; Hypertension; Male; Middle Aged; Perindopril | 2000 |
Blood pressure burden: vascular changes and cerebrovascular complications.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Humans; Hypertension; Perindopril; Stroke | 2000 |
[The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Self Care | 1999 |
Cardiac vagal responsiveness during development in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Baroreflex; Bradycardia; Electric Stimulation; Heart; Heart Rate; Hypertension; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Respiration; Respiration, Artificial; Vagus Nerve | 2000 |
Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Tests; Blood Pressure; Confidence Intervals; Female; Fibrinolytic Agents; Hemostasis; Hemostatics; Humans; Hypertension; Male; Middle Aged; Perindopril; Time Factors | 2000 |
In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Enalapril; ErbB Receptors; Hypertension; Infusions, Intravenous; Male; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Perindopril; Phosphorylation; Rats; Rats, Inbred SHR; Receptors, Platelet-Derived Growth Factor | 2000 |
[New fixed combination for therapy of hypertension. "Softener" and "stimulant" supplement each other].
Topics: Antihypertensive Agents; Drug Combinations; Humans; Hypertension; Indapamide; Perindopril | 2001 |
Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diuretics; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Perindopril; Propranolol; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride Symporter Inhibitors; Ventricular Remodeling | 1999 |
Salt sensitivity in genetically hypertensive rats of the Lyon strain.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Resistance; Hypertension; Kidney; Male; Perindopril; Rats; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan | 2001 |
Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Capillaries; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Hypertension; Hypertrophy, Left Ventricular; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Systole; Ventricular Function, Left | 2001 |
Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study.
Topics: Adult; Aged; Antihypertensive Agents; Arteries; Automation; Blood Pressure; Carotid Arteries; Diuretics; Drug Administration Schedule; Drug Combinations; Elasticity; Equipment and Supplies; Feasibility Studies; Female; Femoral Artery; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Pulse; Time Factors | 2001 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebral Arteries; Chronic Disease; Dilatation, Pathologic; Hypertension; Male; Perindopril; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
Perindopril + indapamide: new preparation. Simple trick.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Perindopril; Treatment Outcome | 1999 |
Combination BP therapy cuts second stroke risk in half.
Topics: Angiotensin-Converting Enzyme Inhibitors; Diuretics; Double-Blind Method; Humans; Hypertension; Indapamide; Middle Aged; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2001 |
Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Vessels; Cardiomegaly; Cardiovascular System; Drug Administration Schedule; Heart Rate; Hydralazine; Hypertension; Kidney; Male; Motor Activity; Perindopril; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Vasodilator Agents | 2001 |
Effect of blood pressure reduction on abnormal left atrial appendage function in untreated systemic hypertensive patients with sinus rhythm.
Topics: Adult; Aged; Antihypertensive Agents; Atrial Appendage; Blood Pressure; Echocardiography, Transesophageal; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Stroke Volume; Systole | 2001 |
Blood-pressure lowering for the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Humans; Hypertension; Perindopril; Stroke | 2001 |
Hypertension. Introduction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Perindopril | 2001 |
Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Hindlimb; Hypertension; Ischemia; Male; Models, Animal; Muscle, Skeletal; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regional Blood Flow | 2001 |
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Benzothiadiazines; Coronary Disease; Diuretics; Humans; Hypertension; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors | 2001 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
Increased absorption of zinc from alimentary tract in primary arterial hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Humans; Hypertension; Intestinal Absorption; Middle Aged; Perindopril; Zinc | 2001 |
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Comorbidity; Cough; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Prevalence; Proteinuria; Receptor, Bradykinin B2; Receptors, Bradykinin; Sex Distribution; Taiwan | 2001 |
[Early prevention of experimental left ventricular hypertrophy in experimental hypertension and angiotensin II levels].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Drug Evaluation, Preclinical; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley | 2001 |
[Management of essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Diuretics; Drug Therapy, Combination; France; Humans; Hydrochlorothiazide; Hypertension; Indapamide; Middle Aged; Patient Selection; Perindopril; Practice Guidelines as Topic; Prognosis; Risk Factors; Societies, Medical; Sodium Chloride Symporter Inhibitors; Time Factors; World Health Organization | 2000 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Research Design; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Causality; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Myocardial Infarction; Perindopril; Stroke | 2001 |
The lowering of blood pressure after stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Stroke | 2001 |
[Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Indapamide; Male; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Recurrence; Risk; Risk Factors; Stroke; Time Factors | 2001 |
[Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diuretics; Humans; Hypertension; Indapamide; International Cooperation; Multicenter Studies as Topic; Perindopril; Preventive Medicine; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2001 |
Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment.
Topics: Animals; Antihypertensive Agents; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Hypertension; Indapamide; Kidney; Natriuresis; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2001 |
Coronary dilatation reserve in experimental hypertension and chronic heart failure: effects of blockade of the renin-angiotensin system.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Coronary Vessels; Gene Deletion; Heart; Heart Failure; Hemodynamics; Hypertension; Irbesartan; Kallikrein-Kinin System; Kallikreins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Bradykinin B2; Receptors, Bradykinin; Renin-Angiotensin System; Tetrazoles; Vasodilation | 2001 |
Progress in reducing the burden of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Clinical Trials as Topic; Ethnicity; Humans; Hypertension; Ischemic Attack, Transient; Perindopril; Risk; Stroke | 2001 |
Perindopril reverses myocyte remodeling in the hypertensive heart.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Cell Count; Cell Size; Dose-Response Relationship, Drug; Echocardiography; Female; Heart; Hypertension; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Ventricular Remodeling | 2002 |
The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Indoles; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril | 1992 |
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Drug Combinations; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Reserpine | 1992 |
Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Cardiomegaly; Hypertension; Hypertrophy; Indoles; Male; Perindopril; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex | 1992 |
Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
Topics: Albuminuria; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Creatinine; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Hypertension; Indoles; Insulin; Male; Middle Aged; Perindopril | 1992 |
Long-term (1 year) acceptability of perindopril in type II diabetic patients with hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Indoles; Lipids; Male; Middle Aged; Perindopril; Time Factors | 1992 |
Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Female; Humans; Hypertension; Indoles; Lipoproteins; Male; Middle Aged; Perindopril | 1992 |
Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Electrolytes; Hydrochlorothiazide; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Urine | 1992 |
No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Hypertension; Indoles; Male; Mesenteric Arteries; Perindopril; Rats; Rats, Inbred SHR; Vascular Resistance | 1991 |
Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Cardiomegaly; Heart; Hemodynamics; Hypertension; Indoles; Myocardium; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
More ACE inhibitors--quinapril, perindopril & ramipril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bridged Bicyclo Compounds; Humans; Hypertension; Indoles; Isoquinolines; Perindopril; Quinapril; Ramipril; Tetrahydroisoquinolines | 1991 |
Reducing pulse pressure in hypertension may normalize small artery structure.
Topics: Animals; Antihypertensive Agents; Arteries; Blood Pressure; Captopril; Dihydropyridines; Heart Rate; Hydralazine; Hypertension; Indoles; Isradipine; Male; Metoprolol; Perindopril; Pulse; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regression Analysis | 1991 |
Development of cardiac hypertrophy and its relationship to the cardiac baroreflex deficit in hypertension.
Topics: Animals; Antihypertensive Agents; Atenolol; Atropine; Blood Pressure; Cardiomegaly; Heart Rate; Hypertension; Indoles; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Vagus Nerve | 1991 |
[International experts commented on the characteristics of perindopril, a new highly potent and well tolerated ACE. Perindopril has been able to reduce the thickness and rigidity of the arterial wall in animal studies].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Humans; Hypertension; Indoles; Perindopril | 1991 |
Effects of perindopril on structural and functional changes in hypertensive arteries.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brachial Artery; Echocardiography; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation | 1991 |
Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, restores the lower limit of autoregulation of cerebral blood flow in the awake renovascular hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Circulation; Heart Rate; Homeostasis; Hypertension; Hypertrophy; Indoles; Kidney; Male; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred Strains | 1990 |
The role of ACE inhibitors in current clinical practice. The place of perindopril: a review. Proceedings of two symposia. 8 November and 15 November, 1989.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Hypertension; Indoles; Perindopril | 1990 |
Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Circulation; Hemodynamics; Homeostasis; Hypertension; Hypertension, Renovascular; Indoles; Male; Perindopril; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance | 1991 |
Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Heart Failure; Hemodynamics; Humans; Hypertension; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Regional Blood Flow; Vascular Resistance; Vasodilation | 1991 |
[Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hypertension; Indoles; Perindopril; Rats; Tissue Distribution | 1991 |
[Role of renin-angiotensin system and vasopressin in the control of blood pressure in genetically hypertensive rats after sympathectomy].
Topics: Animals; Antihypertensive Agents; Blood Pressure; Guanethidine; Hypertension; Indoles; Male; Perindopril; Rats; Renin-Angiotensin System; Sympathectomy, Chemical; Tyramine; Vasopressins | 1990 |
Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Disease Models, Animal; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hypertension; Indoles; Male; Myocardial Contraction; Myocardial Infarction; Myosins; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; RNA, Messenger | 1990 |
Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Cardiovascular Physiological Phenomena; Hemodynamics; Hypertension; Indoles; Perindopril; Rats; Rats, Inbred SHR; Time Factors | 1990 |
[Hypertension and the renin-angiotensin system. The role of perindopril. 1st international Coversyl symposium. Paris, 29 October 1988. Proceedings].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hypertension; Indoles; Perindopril | 1989 |
[Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Diastole; Drug Evaluation; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Monitoring, Physiologic; Perindopril; Systole | 1989 |
Renal function, glycaemic control and perindopril in diabetic patients.
Topics: Albuminuria; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Hypertension; Indoles; Kidney; Middle Aged; Perindopril | 1989 |
Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hydralazine; Hypertension; Indoles; Isradipine; Male; Mesenteric Arteries; Mesenteric Veins; Metoprolol; Perindopril; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1989 |
Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
Topics: Animals; Antihypertensive Agents; Humans; Hypertension; Indoles; Perindopril; Renin-Angiotensin System | 1989 |
Pharmacokinetics of perindopril: therapeutic consequences.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Evaluation; Half-Life; Humans; Hypertension; Indoles; Liver Cirrhosis; Male; Middle Aged; Perindopril; Random Allocation | 1989 |
Hypertension and the renin-angiotensin system. The place of perindopril. Conclusions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Indoles; Perindopril; Renin-Angiotensin System | 1989 |
Antihypertensive effects of S9490-3, a new converting enzyme inhibitor, in the conscious spontaneously hypertensive rat.
Topics: Administration, Oral; Animals; Blood Pressure; Drug Administration Schedule; Heart Rate; Hypertension; Indoles; Injections, Intravenous; Male; Oligopeptides; Perindopril; Rats; Rats, Inbred SHR; Teprotide | 1986 |
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System | 1986 |
Systemic and regional pre- and post-junctional sympathoinhibitory effect of perindopril in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Decerebrate State; Hypertension; Indoles; Kidney; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sympathetic Nervous System; Vascular Resistance | 1986 |
[Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Humans; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1986 |
[The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Indoles; Iodine Radioisotopes; Iothalamic Acid; Kidney; Middle Aged; Natriuresis; Perindopril; Renal Circulation; Vasodilation | 1988 |
Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteries; Carotid Arteries; Compliance; Hypertension; Hypertension, Renovascular; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1988 |
Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure?
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Hypertension; In Vitro Techniques; Indoles; Male; Perindopril; Rats; Rats, Inbred SHR; Vascular Resistance | 1988 |
Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Natriuresis; Perindopril; Renal Circulation; Vascular Resistance | 1988 |
Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diastole; Humans; Hypertension; Indoles; Middle Aged; Monitoring, Physiologic; Perindopril; Systole | 1988 |
Enhanced brachial artery compliance following perindopril in essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Blood Pressure; Brachial Artery; Compliance; Humans; Hypertension; Indoles; Middle Aged; Perindopril | 1988 |